{
  "doc_id": "14",
  "paragraphs": [
    {
      "paragraph_id": "0",
      "paragraph": "围术期血糖管理专家共识(快捷版)",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "围术期血糖管理专家共识(快捷版)",
          "start_idx": 0,
          "end_idx": 16,
          "entities": [
            {
              "entity_id": "T0",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Expert consensus on perioperative blood glucose management (Quick version)"
        }
      ],
      "paragraph_en": "Expert consensus on perioperative blood glucose management (Quick version)"
    },
    {
      "paragraph_id": "1",
      "paragraph": "血糖异常增高是围术期的常见问题。一方面，手术创伤应激诱发机体分泌儿茶酚胺、皮质醇和炎性介质等胰岛素拮抗因子，促使血糖增高。另一方面，合并糖尿病、代谢综合征等胰岛素抵抗或胰岛素分泌障碍疾病的患者更容易发生围术期高血糖。另外，围术期经常使用的激素、含糖营养液等进一步增加了高血糖的风险。值得注意的是，长时间禁食和不恰当的降糖治疗也有引起患者低血糖和血糖剧烈波动的可能。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "血糖异常增高是围术期的常见问题。一方面，手术创伤应激诱发机体分泌儿茶酚胺、皮质醇和炎性介质等胰岛素拮抗因子，促使血糖增高。另一方面，合并糖尿病、代谢综合征等胰岛素抵抗或胰岛素分泌障碍疾病的患者更容易发生围术期高血糖。另外，围术期经常使用的激素、含糖营养液等进一步增加了高血糖的风险。值得注意的是，长时间禁食和不恰当的降糖治疗也有引起患者低血糖和血糖剧烈波动的可能。",
          "start_idx": 0,
          "end_idx": 182,
          "entities": [
            {
              "entity_id": "T1",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T2",
              "entity": "异常增高",
              "entity_type": "Test_Value",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Abnormal increase"
            },
            {
              "entity_id": "T3",
              "entity": "手术创伤",
              "entity_type": "Reason",
              "start_idx": 20,
              "end_idx": 24,
              "entity_en": "Surgical trauma"
            },
            {
              "entity_id": "T4",
              "entity": "应激诱发机体分泌儿茶酚胺、皮质醇和炎性介质等胰岛素拮抗因子",
              "entity_type": "Pathogenesis",
              "start_idx": 24,
              "end_idx": 53,
              "entity_en": "Stress induces the body to secrete insulin antagonists such as catecholamines, cortisol, and inflammatory mediators"
            },
            {
              "entity_id": "T5",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 56,
              "end_idx": 58,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T6",
              "entity": "增高",
              "entity_type": "Test_Value",
              "start_idx": 58,
              "end_idx": 60,
              "entity_en": "Increase"
            },
            {
              "entity_id": "T7",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 68,
              "end_idx": 71,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T8",
              "entity": "代谢综合征",
              "entity_type": "Disease",
              "start_idx": 72,
              "end_idx": 77,
              "entity_en": "Metabolic syndrome"
            },
            {
              "entity_id": "T9",
              "entity": "围术期高血糖",
              "entity_type": "Disease",
              "start_idx": 101,
              "end_idx": 107,
              "entity_en": "Perioperative Hyperglycemia"
            },
            {
              "entity_id": "T10",
              "entity": "围术期",
              "entity_type": "Class",
              "start_idx": 101,
              "end_idx": 104,
              "entity_en": "Perioperative period"
            },
            {
              "entity_id": "T11",
              "entity": "激素",
              "entity_type": "Reason",
              "start_idx": 119,
              "end_idx": 121,
              "entity_en": "hormone"
            },
            {
              "entity_id": "T12",
              "entity": "含糖营养液",
              "entity_type": "Reason",
              "start_idx": 122,
              "end_idx": 127,
              "entity_en": "Sugary nutrient solution"
            },
            {
              "entity_id": "T13",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 134,
              "end_idx": 137,
              "entity_en": "High blood sugar"
            },
            {
              "entity_id": "T14",
              "entity": "长时间禁食",
              "entity_type": "Reason",
              "start_idx": 148,
              "end_idx": 153,
              "entity_en": "Prolonged fasting"
            },
            {
              "entity_id": "T15",
              "entity": "不恰当的降糖治疗",
              "entity_type": "Reason",
              "start_idx": 154,
              "end_idx": 162,
              "entity_en": "Inappropriate glucose-lowering therapy"
            },
            {
              "entity_id": "T16",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 168,
              "end_idx": 171,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T17",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 172,
              "end_idx": 174,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T18",
              "entity": "剧烈波动",
              "entity_type": "Test_Value",
              "start_idx": 174,
              "end_idx": 178,
              "entity_en": "Wild fluctuations"
            },
            {
              "entity_id": "T19",
              "entity": "胰岛素抵抗",
              "entity_type": "Disease",
              "start_idx": 78,
              "end_idx": 83,
              "entity_en": "Insulin resistance"
            },
            {
              "entity_id": "T20",
              "entity": "胰岛素分泌障碍疾病",
              "entity_type": "Disease",
              "start_idx": 84,
              "end_idx": 93,
              "entity_en": "Insulin secretion disorders"
            }
          ],
          "relations": [
            {
              "relation_type": "Class_Disease",
              "relation_id": "R0",
              "head_entity_id": "T10",
              "tail_entity_id": "T9"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R1",
              "head_entity_id": "T11",
              "tail_entity_id": "T13"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R2",
              "head_entity_id": "T12",
              "tail_entity_id": "T13"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R3",
              "head_entity_id": "T14",
              "tail_entity_id": "T16"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R4",
              "head_entity_id": "T15",
              "tail_entity_id": "T16"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R5",
              "head_entity_id": "T17",
              "tail_entity_id": "T16"
            }
          ],
          "sentence_en": "Abnormally high blood sugar is a common problem in the perioperative period. On the one hand, surgical trauma stress induces the body to secrete insulin antagonists such as catecholamines, cortisol and inflammatory mediators, which promote blood sugar levels. On the other hand, patients with combined insulin resistance or insulin secretion disorders such as diabetes and metabolic syndrome are more likely to develop perioperative hyperglycemia. In addition, hormones and sugar-containing nutrient solutions that are frequently used during the perioperative period further increase the risk of hyperglycemia. It is worth noting that long-term fasting and inappropriate hypoglycemic treatments may also cause hypoglycemia and drastic fluctuations in blood sugar in patients."
        }
      ],
      "paragraph_en": "Abnormally high blood sugar is a common problem in the perioperative period. On the one hand, surgical trauma stress induces the body to secrete insulin antagonists such as catecholamines, cortisol and inflammatory mediators, which promote blood sugar levels. On the other hand, patients with combined insulin resistance or insulin secretion disorders such as diabetes and metabolic syndrome are more likely to develop perioperative hyperglycemia. In addition, hormones and sugar-containing nutrient solutions that are frequently used during the perioperative period further increase the risk of hyperglycemia. It is worth noting that long-term fasting and inappropriate hypoglycemic treatments may also cause hypoglycemia and drastic fluctuations in blood sugar in patients."
    },
    {
      "paragraph_id": "2",
      "paragraph": "大量证据表明，围术期血糖异常(包括高血糖、低血糖和血糖波动)增加手术患者的死亡率，增加感染伤口不愈合以及心脑血管事件等并发症的发生率，延长住院时间，影响远期预后。合理的血糖监测和调控是围术期管理的重要组成部分，应当得到重视。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "大量证据表明，围术期血糖异常(包括高血糖、低血糖和血糖波动)增加手术患者的死亡率，增加感染伤口不愈合以及心脑血管事件等并发症的发生率，延长住院时间，影响远期预后。",
          "start_idx": 0,
          "end_idx": 81,
          "entities": [
            {
              "entity_id": "T21",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 10,
              "end_idx": 12,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T22",
              "entity": "异常",
              "entity_type": "Test_Value",
              "start_idx": 12,
              "end_idx": 14,
              "entity_en": "abnormal"
            },
            {
              "entity_id": "T23",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 20,
              "entity_en": "High blood sugar"
            },
            {
              "entity_id": "T24",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 21,
              "end_idx": 24,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T25",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 25,
              "end_idx": 27,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T26",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 27,
              "end_idx": 29,
              "entity_en": "fluctuation"
            },
            {
              "entity_id": "T27",
              "entity": "感染",
              "entity_type": "ADE",
              "start_idx": 43,
              "end_idx": 45,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T28",
              "entity": "伤口不愈合",
              "entity_type": "ADE",
              "start_idx": 45,
              "end_idx": 50,
              "entity_en": "Wounds that do not heal"
            },
            {
              "entity_id": "T29",
              "entity": "心脑血管事件",
              "entity_type": "ADE",
              "start_idx": 52,
              "end_idx": 58,
              "entity_en": "Cardiovascular and cerebrovascular events"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R6",
              "head_entity_id": "T21",
              "tail_entity_id": "T23"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R7",
              "head_entity_id": "T21",
              "tail_entity_id": "T24"
            }
          ],
          "sentence_en": "A large amount of evidence shows that perioperative blood sugar abnormalities (including hyperglycemia, hypoglycemia and blood sugar fluctuations) increase the mortality rate of surgical patients, increase the incidence of complications such as infected wounds that do not heal and cardiovascular and cerebrovascular events, prolong hospitalization time, and affect long-term prognosis."
        },
        {
          "sentence_id": "1",
          "sentence": "合理的血糖监测和调控是围术期管理的重要组成部分，应当得到重视。",
          "start_idx": 81,
          "end_idx": 112,
          "entities": [
            {
              "entity_id": "T30",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Reasonable blood sugar monitoring and regulation are important components of perioperative management and should be taken seriously."
        }
      ],
      "paragraph_en": "A large amount of evidence shows that perioperative blood sugar abnormalities (including hyperglycemia, hypoglycemia, and blood sugar fluctuations) increase the mortality rate of surgical patients, increase the incidence of complications such as infected wounds that do not heal and cardiovascular and cerebrovascular events, prolong hospital stay, and affect long-term prognosis. Reasonable blood sugar monitoring and regulation are important components of perioperative management and should be taken seriously."
    },
    {
      "paragraph_id": "3",
      "paragraph": "据此，中华医学会麻醉学分会于2014年组织专家组起草和制订了《围术期血糖管理专家共识》，本文是在此基础上进一步修订的2015年快捷版本。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "据此，中华医学会麻醉学分会于2014年组织专家组起草和制订了《围术期血糖管理专家共识》，本文是在此基础上进一步修订的2015年快捷版本。",
          "start_idx": 0,
          "end_idx": 68,
          "entities": [
            {
              "entity_id": "T31",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 34,
              "end_idx": 36,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Based on this, the Chinese Medical Association's Anesthesiology Branch organized an expert group to draft and formulate the \"Expert Consensus on Perioperative Blood Glucose Management\" in 2014. This article is a 2015 quick version further revised on this basis."
        }
      ],
      "paragraph_en": "Based on this, the Chinese Medical Association's Anesthesiology Branch organized an expert group to draft and formulate the \"Expert Consensus on Perioperative Blood Glucose Management\" in 2014. This article is a 2015 quick version further revised on this basis."
    },
    {
      "paragraph_id": "4",
      "paragraph": "围术期血糖管理的基本原则",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "围术期血糖管理的基本原则",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T32",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Basic principles of perioperative blood glucose management"
        }
      ],
      "paragraph_en": "Basic principles of perioperative blood sugar management"
    },
    {
      "paragraph_id": "5",
      "paragraph": "识别围术期血糖异常的高危人群围术期血糖异常以高血糖为主，可分为合并糖尿病的高血糖和应激性高血糖两类(stress-induced hyperglycemia)。一般手术围术期高血糖以合并糖尿病者居多。目前我国糖尿病患病率逐年增高，合并糖尿病的外科手术患者也日趋增多，其中相当比例的患者术前并未得到正确诊断和有效控制。有国外研究报道，择期手术中10%以上的患者合并隐匿性糖尿病。与普通人群相比，合并糖尿病尤其是未发现、未治疗的糖尿病患者血糖升高更加显著，围术期死亡率和并发症发生率更高，应当在术前加以识别。而单纯由于应激导致血糖显著增高者往往提示手术应激很强，或合并感染、败血症等并发症，可能为危重患者。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "识别围术期血糖异常的高危人群围术期血糖异常以高血糖为主，可分为合并糖尿病的高血糖和应激性高血糖两类(stress-induced hyperglycemia)。一般手术围术期高血糖以合并糖尿病者居多。目前我国糖尿病患病率逐年增高，合并糖尿病的外科手术患者也日趋增多，其中相当比例的患者术前并未得到正确诊断和有效控制。有国外研究报道，择期手术中10%以上的患者合并隐匿性糖尿病。与普通人群相比，合并糖尿病尤其是未发现、未治疗的糖尿病患者血糖升高更加显著，围术期死亡率和并发症发生率更高，应当在术前加以识别。",
          "start_idx": 0,
          "end_idx": 252,
          "entities": [
            {
              "entity_id": "T33",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 5,
              "end_idx": 7,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T34",
              "entity": "异常",
              "entity_type": "Test_Value",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "abnormal"
            },
            {
              "entity_id": "T35",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 17,
              "end_idx": 19,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T36",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 22,
              "end_idx": 25,
              "entity_en": "High blood sugar"
            },
            {
              "entity_id": "T37",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 36,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T38",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 37,
              "end_idx": 40,
              "entity_en": "High blood sugar"
            },
            {
              "entity_id": "T39",
              "entity": "应激性高血糖",
              "entity_type": "Disease",
              "start_idx": 41,
              "end_idx": 47,
              "entity_en": "Stress-induced hyperglycemia"
            },
            {
              "entity_id": "T40",
              "entity": "应激性",
              "entity_type": "Class",
              "start_idx": 41,
              "end_idx": 44,
              "entity_en": "Stress"
            },
            {
              "entity_id": "T41",
              "entity": "stress-induced hyperglycemia",
              "entity_type": "Disease",
              "start_idx": 50,
              "end_idx": 78,
              "entity_en": "stress-induced hyperglycemia"
            },
            {
              "entity_id": "T42",
              "entity": "围术期高血糖",
              "entity_type": "Disease",
              "start_idx": 84,
              "end_idx": 90,
              "entity_en": "Perioperative Hyperglycemia"
            },
            {
              "entity_id": "T43",
              "entity": "围术期",
              "entity_type": "Class",
              "start_idx": 84,
              "end_idx": 87,
              "entity_en": "Perioperative period"
            },
            {
              "entity_id": "T44",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 93,
              "end_idx": 96,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T45",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 104,
              "end_idx": 107,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T46",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 117,
              "end_idx": 120,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T47",
              "entity": "隐匿性糖尿病",
              "entity_type": "Disease",
              "start_idx": 181,
              "end_idx": 187,
              "entity_en": "Latent diabetes"
            },
            {
              "entity_id": "T48",
              "entity": "隐匿性",
              "entity_type": "Class",
              "start_idx": 181,
              "end_idx": 184,
              "entity_en": "Hidden"
            },
            {
              "entity_id": "T49",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 198,
              "end_idx": 201,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T50",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 212,
              "end_idx": 215,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T51",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 217,
              "end_idx": 219,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T52",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 219,
              "end_idx": 221,
              "entity_en": "Elevated"
            },
            {
              "entity_id": "T59",
              "entity": "异常",
              "entity_type": "Test_Value",
              "start_idx": 19,
              "end_idx": 21,
              "entity_en": "abnormal"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R8",
              "head_entity_id": "T35",
              "tail_entity_id": "T36"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R9",
              "head_entity_id": "T35",
              "tail_entity_id": "T37"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R10",
              "head_entity_id": "T35",
              "tail_entity_id": "T38"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R11",
              "head_entity_id": "T35",
              "tail_entity_id": "T39"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R12",
              "head_entity_id": "T35",
              "tail_entity_id": "T41"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R13",
              "head_entity_id": "T40",
              "tail_entity_id": "T39"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R14",
              "head_entity_id": "T43",
              "tail_entity_id": "T42"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R15",
              "head_entity_id": "T48",
              "tail_entity_id": "T47"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R16",
              "head_entity_id": "T51",
              "tail_entity_id": "T49"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R17",
              "head_entity_id": "T51",
              "tail_entity_id": "T50"
            }
          ],
          "sentence_en": "Identify high-risk groups for perioperative blood sugar abnormalities. Perioperative blood sugar abnormalities are mainly hyperglycemia, which can be divided into hyperglycemia with diabetes and stress-induced hyperglycemia. In general, perioperative hyperglycemia is more common in patients with diabetes. At present, the prevalence of diabetes in my country is increasing year by year, and the number of surgical patients with diabetes is also increasing. A considerable proportion of these patients have not been correctly diagnosed and effectively controlled before surgery. Foreign studies have reported that more than 10% of patients in elective surgery have occult diabetes. Compared with the general population, patients with diabetes, especially those with undetected and untreated diabetes, have more significant blood sugar increases, higher perioperative mortality and complication rates, and should be identified before surgery."
        },
        {
          "sentence_id": "1",
          "sentence": "而单纯由于应激导致血糖显著增高者往往提示手术应激很强，或合并感染、败血症等并发症，可能为危重患者。",
          "start_idx": 252,
          "end_idx": 301,
          "entities": [
            {
              "entity_id": "T53",
              "entity": "应激",
              "entity_type": "Reason",
              "start_idx": 5,
              "end_idx": 7,
              "entity_en": "Stress"
            },
            {
              "entity_id": "T54",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 9,
              "end_idx": 11,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T55",
              "entity": "显著增高",
              "entity_type": "Test_Value",
              "start_idx": 11,
              "end_idx": 15,
              "entity_en": "Significantly increased"
            },
            {
              "entity_id": "T56",
              "entity": "手术应激",
              "entity_type": "Reason",
              "start_idx": 20,
              "end_idx": 24,
              "entity_en": "Surgical stress"
            },
            {
              "entity_id": "T57",
              "entity": "感染",
              "entity_type": "Disease",
              "start_idx": 30,
              "end_idx": 32,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T58",
              "entity": "败血症",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 36,
              "entity_en": "septicemia"
            }
          ],
          "relations": [],
          "sentence_en": "Patients whose blood sugar levels increase significantly simply due to stress often have very strong surgical stress, or have complications such as infection, sepsis, etc., and may be critically ill patients."
        }
      ],
      "paragraph_en": "Identify high-risk groups for perioperative blood sugar abnormalities Perioperative blood sugar abnormalities are mainly hyperglycemia, which can be divided into hyperglycemia with diabetes and stress-induced hyperglycemia. In general, perioperative hyperglycemia is more common in patients with diabetes. At present, the prevalence of diabetes in my country is increasing year by year, and the number of surgical patients with diabetes is also increasing. A considerable proportion of these patients have not been correctly diagnosed and effectively controlled before surgery. Foreign studies have reported that more than 10% of patients in elective surgery have occult diabetes. Compared with the general population, patients with diabetes, especially those with undetected and untreated diabetes, have more significant blood sugar increases, higher perioperative mortality and complication rates, and should be identified before surgery. However, patients with significant increases in blood sugar simply due to stress often indicate that the surgical stress is very strong, or have complications such as infection and sepsis, and may be critically ill patients."
    },
    {
      "paragraph_id": "6",
      "paragraph": "合理的血糖控制目标大量循证医学证据表明，血糖控制有利于减少外科重症患者术后感染等并发症，但控制过于严格(如降至“正常”范围)则增加低血糖风险，对降低总死亡率并无益处。尽管目前的结论主要来源于对ICU重症患者以及体外循环心脏手术患者的研究，对一般外科手术患者的理想血糖值尚缺乏高级别的研究证据，但采用适当宽松的血糖控制目标已得到了广泛的共识。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "合理的血糖控制目标大量循证医学证据表明，血糖控制有利于减少外科重症患者术后感染等并发症，但控制过于严格(如降至“正常”范围)则增加低血糖风险，对降低总死亡率并无益处。",
          "start_idx": 0,
          "end_idx": 83,
          "entities": [
            {
              "entity_id": "T60",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T61",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 20,
              "end_idx": 22,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T65",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 65,
              "end_idx": 68,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T66",
              "entity": "术后感染",
              "entity_type": "ADE",
              "start_idx": 35,
              "end_idx": 39,
              "entity_en": "Postoperative infection"
            }
          ],
          "relations": [],
          "sentence_en": "Reasonable blood sugar control targets A large amount of evidence-based medical evidence shows that blood sugar control is beneficial to reducing complications such as postoperative infection in critically ill surgical patients, but overly strict control (such as reducing it to the \"normal\" range) increases the risk of hypoglycemia and is not beneficial in reducing the overall mortality rate."
        },
        {
          "sentence_id": "1",
          "sentence": "尽管目前的结论主要来源于对ICU重症患者以及体外循环心脏手术患者的研究，对一般外科手术患者的理想血糖值尚缺乏高级别的研究证据，但采用适当宽松的血糖控制目标已得到了广泛的共识。",
          "start_idx": 83,
          "end_idx": 170,
          "entities": [
            {
              "entity_id": "T62",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 71,
              "end_idx": 73,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T63",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 48,
              "end_idx": 50,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T64",
              "entity": "外循环心脏手术",
              "entity_type": "Operation",
              "start_idx": 23,
              "end_idx": 30,
              "entity_en": "Extracorporeal heart surgery"
            }
          ],
          "relations": [],
          "sentence_en": "Although the current conclusions are mainly derived from studies on critically ill ICU patients and patients undergoing extracorporeal circulation heart surgery, and there is still a lack of high-level research evidence on the ideal blood sugar levels for general surgical patients, there is a broad consensus on the use of appropriately loose blood sugar control targets."
        }
      ],
      "paragraph_en": "Reasonable blood sugar control target A large amount of evidence-based medical evidence shows that blood sugar control is beneficial to reduce complications such as postoperative infection in critically ill surgical patients, but too strict control (such as reducing it to the \"normal\" range) increases the risk of hypoglycemia and has no benefit in reducing the overall mortality rate. Although the current conclusions are mainly derived from studies on critically ill ICU patients and patients undergoing extracorporeal circulation heart surgery, there is still a lack of high-level research evidence on the ideal blood sugar value for general surgical patients, but the use of appropriately loose blood sugar control targets has been widely agreed upon."
    },
    {
      "paragraph_id": "7",
      "paragraph": "围术期血糖管理的要点围术期血糖管理的要点在于控制高血糖，同时避免发生低血糖，维持血糖平稳。因禁食、降糖方案未及时调整或降糖治疗中断等因素造成的围术期血糖波动比稳定的高血糖危害更大。严密的血糖监测、及时调整降糖治疗方案是保持围术期血糖平稳的关键。应根据患者术前血糖水平、治疗方案、有无并发症、手术类型等进行全面评估，制定个体化的管理方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "围术期血糖管理的要点围术期血糖管理的要点在于控制高血糖，同时避免发生低血糖，维持血糖平稳。因禁食、降糖方案未及时调整或降糖治疗中断等因素造成的围术期血糖波动比稳定的高血糖危害更大。",
          "start_idx": 0,
          "end_idx": 90,
          "entities": [
            {
              "entity_id": "T67",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T68",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T69",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 27,
              "entity_en": "High blood sugar"
            },
            {
              "entity_id": "T70",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 34,
              "end_idx": 37,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T71",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 40,
              "end_idx": 42,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T72",
              "entity": "禁食",
              "entity_type": "Treatment",
              "start_idx": 46,
              "end_idx": 48,
              "entity_en": "fasting"
            },
            {
              "entity_id": "T73",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 74,
              "end_idx": 76,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T74",
              "entity": "波动比稳定",
              "entity_type": "Test_Value",
              "start_idx": 76,
              "end_idx": 81,
              "entity_en": "Fluctuation is more stable than"
            },
            {
              "entity_id": "T75",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 82,
              "end_idx": 85,
              "entity_en": "High blood sugar"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R18",
              "head_entity_id": "T67",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R19",
              "head_entity_id": "T67",
              "tail_entity_id": "T70"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R20",
              "head_entity_id": "T68",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R21",
              "head_entity_id": "T68",
              "tail_entity_id": "T70"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R22",
              "head_entity_id": "T71",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R23",
              "head_entity_id": "T71",
              "tail_entity_id": "T70"
            },
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R24",
              "head_entity_id": "T72",
              "tail_entity_id": "T75"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R25",
              "head_entity_id": "T73",
              "tail_entity_id": "T75"
            }
          ],
          "sentence_en": "The key points of perioperative blood sugar management are to control hyperglycemia, avoid hypoglycemia, and maintain blood sugar stability. Perioperative blood sugar fluctuations caused by fasting, failure to adjust the hypoglycemic regimen in time, or interruption of hypoglycemic treatment are more harmful than stable hyperglycemia."
        },
        {
          "sentence_id": "1",
          "sentence": "严密的血糖监测、及时调整降糖治疗方案是保持围术期血糖平稳的关键。",
          "start_idx": 90,
          "end_idx": 122,
          "entities": [
            {
              "entity_id": "T76",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T77",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 24,
              "end_idx": 26,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T78",
              "entity": "平稳",
              "entity_type": "Test_Value",
              "start_idx": 26,
              "end_idx": 28,
              "entity_en": "smooth"
            }
          ],
          "relations": [],
          "sentence_en": "Strict blood sugar monitoring and timely adjustment of hypoglycemic treatment plans are the key to maintaining stable blood sugar levels during the perioperative period."
        },
        {
          "sentence_id": "2",
          "sentence": "应根据患者术前血糖水平、治疗方案、有无并发症、手术类型等进行全面评估，制定个体化的管理方案。",
          "start_idx": 122,
          "end_idx": 168,
          "entities": [
            {
              "entity_id": "T79",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "A comprehensive assessment should be conducted based on the patient's preoperative blood sugar level, treatment plan, presence of complications, type of surgery, etc., and an individualized management plan should be developed."
        }
      ],
      "paragraph_en": "The key points of perioperative blood sugar management The key points of perioperative blood sugar management are to control hyperglycemia, avoid hypoglycemia, and maintain blood sugar stability. Perioperative blood sugar fluctuations caused by fasting, failure to adjust the hypoglycemic regimen in time, or interruption of hypoglycemic treatment are more harmful than stable hyperglycemia. Strict blood sugar monitoring and timely adjustment of hypoglycemic treatment regimens are the key to maintaining stable perioperative blood sugar. A comprehensive assessment should be conducted based on the patient's preoperative blood sugar level, treatment regimen, presence of complications, type of surgery, etc., and an individualized management plan should be developed."
    },
    {
      "paragraph_id": "8",
      "paragraph": "血糖术前评估与术前准备",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "血糖术前评估与术前准备",
          "start_idx": 0,
          "end_idx": 11,
          "entities": [
            {
              "entity_id": "T80",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Preoperative blood sugar assessment and preoperative preparation"
        }
      ],
      "paragraph_en": "Preoperative blood sugar assessment and preoperative preparation"
    },
    {
      "paragraph_id": "9",
      "paragraph": "术前评估",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "术前评估",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": [],
          "sentence_en": "Preoperative evaluation"
        }
      ],
      "paragraph_en": "Preoperative evaluation"
    },
    {
      "paragraph_id": "10",
      "paragraph": "1.糖化血红蛋白HbA1c反映采血前三个月的平均血糖水平，可用于术前筛查糖尿病和评价血糖控制效果。对既往无糖尿病病史者，如果年龄≥45岁或体重指数BMI≥25kg/m2，同时合并高血压、高血脂、心血管疾病、糖尿病家族史等高危因素，行心脏外科、神经外科、骨科、创伤外科、器官移植等高危手术者，推荐术前筛查HbA1c；HbA1c≥6.5%即可诊断糖尿病。既往已有明确糖尿病病史的患者，HbA1c≤7%提示血糖控制满意，围术期风险较低；HbA1c>8.5%者建议考虑推迟择期手术。单纯应激性高血糖者HbA1c正常。注意贫血、近期输血等因素可能干扰HbA1c测量的准确性。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.糖化血红蛋白HbA1c反映采血前三个月的平均血糖水平，可用于术前筛查糖尿病和评价血糖控制效果。对既往无糖尿病病史者，如果年龄≥45岁或体重指数BMI≥25kg/m2，同时合并高血压、高血脂、心血管疾病、糖尿病家族史等高危因素，行心脏外科、神经外科、骨科、创伤外科、器官移植等高危手术者，推荐术前筛查HbA1c；HbA1c≥6.5%即可诊断糖尿病。既往已有明确糖尿病病史的患者，HbA1c≤7%提示血糖控制满意，围术期风险较低；HbA1c>8.5%者建议考虑推迟择期手术。单纯应激性高血糖者HbA1c正常。",
          "start_idx": 0,
          "end_idx": 254,
          "entities": [
            {
              "entity_id": "T81",
              "entity": "糖化血红蛋白HbA1c",
              "entity_type": "Test_items",
              "start_idx": 2,
              "end_idx": 13,
              "entity_en": "Glycated hemoglobin HbA1c"
            },
            {
              "entity_id": "T82",
              "entity": "采血",
              "entity_type": "Test",
              "start_idx": 15,
              "end_idx": 17,
              "entity_en": "Blood collection"
            },
            {
              "entity_id": "T83",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 24,
              "end_idx": 26,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T84",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 36,
              "end_idx": 39,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T85",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 42,
              "end_idx": 44,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T86",
              "entity": "高血压",
              "entity_type": "Disease",
              "start_idx": 89,
              "end_idx": 92,
              "entity_en": "hypertension"
            },
            {
              "entity_id": "T87",
              "entity": "高血脂",
              "entity_type": "Disease",
              "start_idx": 93,
              "end_idx": 96,
              "entity_en": "High cholesterol"
            },
            {
              "entity_id": "T88",
              "entity": "心血管疾病",
              "entity_type": "Disease",
              "start_idx": 97,
              "end_idx": 102,
              "entity_en": "Cardiovascular disease"
            },
            {
              "entity_id": "T89",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 97,
              "end_idx": 100,
              "entity_en": "Cardiovascular"
            },
            {
              "entity_id": "T90",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 103,
              "end_idx": 106,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T91",
              "entity": "器官移植",
              "entity_type": "Operation",
              "start_idx": 134,
              "end_idx": 138,
              "entity_en": "Organ transplantation"
            },
            {
              "entity_id": "T92",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 151,
              "end_idx": 156,
              "entity_en": "HbA1c"
            },
            {
              "entity_id": "T93",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 157,
              "end_idx": 162,
              "entity_en": "HbA1c"
            },
            {
              "entity_id": "T94",
              "entity": "≥6.5%",
              "entity_type": "Test_Value",
              "start_idx": 162,
              "end_idx": 167,
              "entity_en": "≥6.5%"
            },
            {
              "entity_id": "T95",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 171,
              "end_idx": 174,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T96",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 181,
              "end_idx": 184,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T97",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 190,
              "end_idx": 195,
              "entity_en": "HbA1c"
            },
            {
              "entity_id": "T98",
              "entity": "≤7%",
              "entity_type": "Test_Value",
              "start_idx": 195,
              "end_idx": 198,
              "entity_en": "≤7%"
            },
            {
              "entity_id": "T99",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 200,
              "end_idx": 202,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T100",
              "entity": "控制满意",
              "entity_type": "Test_Value",
              "start_idx": 202,
              "end_idx": 206,
              "entity_en": "Control satisfaction"
            },
            {
              "entity_id": "T101",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 215,
              "end_idx": 220,
              "entity_en": "HbA1c"
            },
            {
              "entity_id": "T102",
              "entity": ">8.5%",
              "entity_type": "Test_Value",
              "start_idx": 220,
              "end_idx": 225,
              "entity_en": ">8.5%"
            },
            {
              "entity_id": "T103",
              "entity": "应激性高血糖",
              "entity_type": "Disease",
              "start_idx": 239,
              "end_idx": 245,
              "entity_en": "Stress-induced hyperglycemia"
            },
            {
              "entity_id": "T104",
              "entity": "应激性",
              "entity_type": "Class",
              "start_idx": 239,
              "end_idx": 242,
              "entity_en": "Stress"
            },
            {
              "entity_id": "T105",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 246,
              "end_idx": 251,
              "entity_en": "HbA1c"
            },
            {
              "entity_id": "T106",
              "entity": "正常",
              "entity_type": "Test_Value",
              "start_idx": 251,
              "end_idx": 253,
              "entity_en": "normal"
            },
            {
              "entity_id": "T110",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 53,
              "end_idx": 56,
              "entity_en": "diabetes"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R26",
              "head_entity_id": "T81",
              "tail_entity_id": "T84"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R27",
              "head_entity_id": "T82",
              "tail_entity_id": "T84"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R28",
              "head_entity_id": "T83",
              "tail_entity_id": "T84"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R29",
              "head_entity_id": "T85",
              "tail_entity_id": "T84"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R30",
              "head_entity_id": "T89",
              "tail_entity_id": "T88"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R31",
              "head_entity_id": "T91",
              "tail_entity_id": "T95"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R32",
              "head_entity_id": "T92",
              "tail_entity_id": "T95"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R33",
              "head_entity_id": "T93",
              "tail_entity_id": "T95"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R34",
              "head_entity_id": "T97",
              "tail_entity_id": "T96"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R35",
              "head_entity_id": "T99",
              "tail_entity_id": "T96"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R36",
              "head_entity_id": "T101",
              "tail_entity_id": "T96"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R37",
              "head_entity_id": "T104",
              "tail_entity_id": "T103"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R38",
              "head_entity_id": "T105",
              "tail_entity_id": "T103"
            }
          ],
          "sentence_en": "1. Glycated hemoglobin HbA1c reflects the average blood sugar level in the three months before blood collection, and can be used to screen for diabetes and evaluate the effect of blood sugar control before surgery. For patients with no history of diabetes, if they are ≥45 years old or have a body mass index BMI ≥25kg/m2, and have high-risk factors such as hypertension, hyperlipidemia, cardiovascular disease, family history of diabetes, and undergo high-risk surgeries such as cardiac surgery, neurosurgery, orthopedics, trauma surgery, and organ transplantation, it is recommended to screen HbA1c before surgery; HbA1c ≥6.5% can diagnose diabetes. For patients with a clear history of diabetes, HbA1c ≤7% indicates satisfactory blood sugar control and low perioperative risk; those with HbA1c>8.5% are advised to consider postponing elective surgery. Those with simple stress hyperglycemia have normal HbA1c."
        },
        {
          "sentence_id": "1",
          "sentence": "注意贫血、近期输血等因素可能干扰HbA1c测量的准确性。",
          "start_idx": 254,
          "end_idx": 282,
          "entities": [
            {
              "entity_id": "T107",
              "entity": "贫血",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 4,
              "entity_en": "anemia"
            },
            {
              "entity_id": "T108",
              "entity": "输血",
              "entity_type": "Treatment",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "Blood transfusion"
            },
            {
              "entity_id": "T109",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 16,
              "end_idx": 21,
              "entity_en": "HbA1c"
            }
          ],
          "relations": [],
          "sentence_en": "Note that factors such as anemia and recent blood transfusion may interfere with the accuracy of HbA1c measurement."
        }
      ],
      "paragraph_en": "1. Glycated hemoglobin HbA1c reflects the average blood sugar level in the three months before blood collection, and can be used to screen for diabetes and evaluate the effect of blood sugar control before surgery. For patients with no history of diabetes, if they are ≥45 years old or have a body mass index BMI ≥25kg/m2, and have high-risk factors such as hypertension, hyperlipidemia, cardiovascular disease, family history of diabetes, and undergo high-risk surgeries such as cardiac surgery, neurosurgery, orthopedics, trauma surgery, and organ transplantation, it is recommended to screen HbA1c before surgery; HbA1c ≥6.5% can diagnose diabetes. For patients with a clear history of diabetes, HbA1c ≤7% indicates satisfactory blood sugar control and low perioperative risk; those with HbA1c>8.5% are advised to consider postponing elective surgery. HbA1c is normal in patients with simple stress hyperglycemia. Note that factors such as anemia and recent blood transfusions may interfere with the accuracy of HbA1c measurement."
    },
    {
      "paragraph_id": "11",
      "paragraph": "2.对合并糖尿病的患者，术前还应了解糖尿病类型、病程、目前的治疗方案、低血糖发作情况，特别是有无糖尿病并发症。合并糖尿病酮症酸中毒、高渗综合症是非急诊手术的禁忌。病程长的糖尿病患者可能并发冠心病等心脑血管疾病，且心肌缺血症状往往不典型、容易漏诊，应引起警惕。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.对合并糖尿病的患者，术前还应了解糖尿病类型、病程、目前的治疗方案、低血糖发作情况，特别是有无糖尿病并发症。合并糖尿病酮症酸中毒、高渗综合症是非急诊手术的禁忌。病程长的糖尿病患者可能并发冠心病等心脑血管疾病，且心肌缺血症状往往不典型、容易漏诊，应引起警惕。",
          "start_idx": 0,
          "end_idx": 129,
          "entities": [
            {
              "entity_id": "T111",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 8,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T112",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 18,
              "end_idx": 21,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T113",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 35,
              "end_idx": 38,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T114",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 48,
              "end_idx": 51,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T115",
              "entity": "糖尿病酮症酸中毒",
              "entity_type": "Disease",
              "start_idx": 57,
              "end_idx": 65,
              "entity_en": "Diabetic ketoacidosis"
            },
            {
              "entity_id": "T116",
              "entity": "高渗综合症",
              "entity_type": "Disease",
              "start_idx": 66,
              "end_idx": 71,
              "entity_en": "Hyperosmotic syndrome"
            },
            {
              "entity_id": "T117",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 85,
              "end_idx": 88,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T118",
              "entity": "冠心病",
              "entity_type": "Disease",
              "start_idx": 94,
              "end_idx": 97,
              "entity_en": "Coronary heart disease"
            },
            {
              "entity_id": "T119",
              "entity": "心脑血管疾病",
              "entity_type": "Disease",
              "start_idx": 98,
              "end_idx": 104,
              "entity_en": "Cardiovascular and cerebrovascular diseases"
            },
            {
              "entity_id": "T120",
              "entity": "心脑血管",
              "entity_type": "Anatomy",
              "start_idx": 98,
              "end_idx": 102,
              "entity_en": "Cardiovascular"
            },
            {
              "entity_id": "T121",
              "entity": "心肌缺血",
              "entity_type": "Disease",
              "start_idx": 106,
              "end_idx": 110,
              "entity_en": "Myocardial ischemia"
            },
            {
              "entity_id": "T122",
              "entity": "心肌",
              "entity_type": "Anatomy",
              "start_idx": 106,
              "end_idx": 108,
              "entity_en": "Myocardium"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R39",
              "head_entity_id": "T120",
              "tail_entity_id": "T119"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R40",
              "head_entity_id": "T122",
              "tail_entity_id": "T121"
            }
          ],
          "sentence_en": "2. For patients with diabetes, the type of diabetes, course of disease, current treatment plan, hypoglycemia, and especially the presence of diabetic complications should be understood before surgery. Concomitant diabetic ketoacidosis and hyperosmolar syndrome are contraindications for non-emergency surgery. Patients with diabetes with a long course of disease may have coronary heart disease and other cardiovascular and cerebrovascular diseases, and the symptoms of myocardial ischemia are often atypical and easily missed, which should be a cause of vigilance."
        }
      ],
      "paragraph_en": "2. For patients with diabetes, the type of diabetes, course of disease, current treatment plan, hypoglycemia, and especially the presence of diabetic complications should be understood before surgery. Concomitant diabetic ketoacidosis and hyperosmolar syndrome are contraindications for non-emergency surgery. Patients with diabetes with a long course of disease may have coronary heart disease and other cardiovascular and cerebrovascular diseases, and the symptoms of myocardial ischemia are often atypical and easily missed, which should be a cause of vigilance."
    },
    {
      "paragraph_id": "12",
      "paragraph": "3.手术类型与围术期高血糖风险相关。手术越大、应激越强，血糖增高越明显。与区域麻醉比较，全身麻醉特别是吸入性麻醉药刺激血糖升高的作用更显著，但目前并没有证据证明糖尿病患者必须首选区域麻醉。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.手术类型与围术期高血糖风险相关。手术越大、应激越强，血糖增高越明显。与区域麻醉比较，全身麻醉特别是吸入性麻醉药刺激血糖升高的作用更显著，但目前并没有证据证明糖尿病患者必须首选区域麻醉。",
          "start_idx": 0,
          "end_idx": 94,
          "entities": [
            {
              "entity_id": "T123",
              "entity": "围术期高血糖",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 13,
              "entity_en": "Perioperative Hyperglycemia"
            },
            {
              "entity_id": "T124",
              "entity": "手术越大",
              "entity_type": "Reason",
              "start_idx": 18,
              "end_idx": 22,
              "entity_en": "The bigger the surgery"
            },
            {
              "entity_id": "T125",
              "entity": "应激越强",
              "entity_type": "Reason",
              "start_idx": 23,
              "end_idx": 27,
              "entity_en": "The stronger the stress"
            },
            {
              "entity_id": "T126",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 28,
              "end_idx": 30,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T127",
              "entity": "增高",
              "entity_type": "Test_Value",
              "start_idx": 30,
              "end_idx": 32,
              "entity_en": "Increase"
            },
            {
              "entity_id": "T128",
              "entity": "区域麻醉",
              "entity_type": "Operation",
              "start_idx": 37,
              "end_idx": 41,
              "entity_en": "Regional anesthesia"
            },
            {
              "entity_id": "T129",
              "entity": "全身麻醉",
              "entity_type": "Operation",
              "start_idx": 44,
              "end_idx": 48,
              "entity_en": "General anesthesia"
            },
            {
              "entity_id": "T130",
              "entity": "区域麻醉",
              "entity_type": "Operation",
              "start_idx": 89,
              "end_idx": 93,
              "entity_en": "Regional anesthesia"
            },
            {
              "entity_id": "T131",
              "entity": "吸入性麻醉药",
              "entity_type": "Drug",
              "start_idx": 51,
              "end_idx": 57,
              "entity_en": "Inhalation anesthetics"
            },
            {
              "entity_id": "T132",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 59,
              "end_idx": 61,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T133",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 61,
              "end_idx": 63,
              "entity_en": "Elevated"
            },
            {
              "entity_id": "T134",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 80,
              "end_idx": 83,
              "entity_en": "diabetes"
            }
          ],
          "relations": [
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R41",
              "head_entity_id": "T128",
              "tail_entity_id": "T134"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R42",
              "head_entity_id": "T129",
              "tail_entity_id": "T134"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R43",
              "head_entity_id": "T130",
              "tail_entity_id": "T134"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R44",
              "head_entity_id": "T131",
              "tail_entity_id": "T134"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R45",
              "head_entity_id": "T132",
              "tail_entity_id": "T134"
            }
          ],
          "sentence_en": "3. The type of surgery is associated with the risk of perioperative hyperglycemia. The larger the surgery and the greater the stress, the more obvious the increase in blood sugar. Compared with regional anesthesia, general anesthesia, especially inhaled anesthetics, has a more significant effect in stimulating blood sugar increase, but there is currently no evidence that regional anesthesia must be the first choice for diabetic patients."
        }
      ],
      "paragraph_en": "3. The type of surgery is associated with the risk of perioperative hyperglycemia. The larger the surgery and the greater the stress, the more obvious the increase in blood sugar. Compared with regional anesthesia, general anesthesia, especially inhaled anesthetics, has a more significant effect on stimulating blood sugar increase, but there is currently no evidence that regional anesthesia must be the first choice for diabetic patients."
    },
    {
      "paragraph_id": "13",
      "paragraph": "术前准备",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "术前准备",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": [],
          "sentence_en": "Preoperative preparation"
        }
      ],
      "paragraph_en": "Preoperative preparation"
    },
    {
      "paragraph_id": "14",
      "paragraph": "胰岛素是围术期唯一安全的降糖药物。术前应将原有降糖方案过渡至胰岛素，并根据禁食情况减去控制餐后血糖的胰岛素剂量。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "胰岛素是围术期唯一安全的降糖药物。",
          "start_idx": 0,
          "end_idx": 17,
          "entities": [
            {
              "entity_id": "T135",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 3,
              "entity_en": "insulin"
            }
          ],
          "relations": [],
          "sentence_en": "Insulin is the only safe glucose-lowering drug during the perioperative period."
        },
        {
          "sentence_id": "1",
          "sentence": "术前应将原有降糖方案过渡至胰岛素，并根据禁食情况减去控制餐后血糖的胰岛素剂量。",
          "start_idx": 17,
          "end_idx": 56,
          "entities": [
            {
              "entity_id": "T136",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 13,
              "end_idx": 16,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T137",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 33,
              "end_idx": 36,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T138",
              "entity": "禁食",
              "entity_type": "Treatment",
              "start_idx": 20,
              "end_idx": 22,
              "entity_en": "fasting"
            },
            {
              "entity_id": "T139",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 28,
              "end_idx": 32,
              "entity_en": "Postprandial blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Before surgery, the original glucose-lowering regimen should be transitioned to insulin, and the insulin dose for controlling postprandial blood sugar should be subtracted based on the fasting situation."
        }
      ],
      "paragraph_en": "Insulin is the only safe hypoglycemic drug in the perioperative period. Before surgery, the original hypoglycemic regimen should be transitioned to insulin, and the insulin dose for controlling postprandial blood sugar should be subtracted according to the fasting situation."
    },
    {
      "paragraph_id": "15",
      "paragraph": "1.糖尿病患者手术当日停用口服降糖药和非胰岛素注射剂。磺脲类和格列奈类口服降糖药可能造成低血糖，术前应停用至少24小时；二甲双胍有引起乳酸酸中毒的风险，肾功能不全者术前停用24~48小时。停药期间监测血糖，使用常规胰岛素控制血糖水平。术前住院时间超过3天的患者可在入院后即换用短效胰岛素皮下注射控制血糖，术前调整到适合的剂量。无需禁食水的短小局麻手术可保留口服降糖药。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.糖尿病患者手术当日停用口服降糖药和非胰岛素注射剂。磺脲类和格列奈类口服降糖药可能造成低血糖，术前应停用至少24小时；二甲双胍有引起乳酸酸中毒的风险，肾功能不全者术前停用24~48小时。",
          "start_idx": 0,
          "end_idx": 94,
          "entities": [
            {
              "entity_id": "T140",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 5,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T141",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "oral"
            },
            {
              "entity_id": "T142",
              "entity": "非胰岛素注射剂",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 26,
              "entity_en": "Non-insulin injections"
            },
            {
              "entity_id": "T143",
              "entity": "磺脲类",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 30,
              "entity_en": "Sulfonylureas"
            },
            {
              "entity_id": "T144",
              "entity": "格列奈类口服降糖药",
              "entity_type": "Drug",
              "start_idx": 31,
              "end_idx": 40,
              "entity_en": "Meglitinides oral hypoglycemic drugs"
            },
            {
              "entity_id": "T145",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 35,
              "end_idx": 37,
              "entity_en": "oral"
            },
            {
              "entity_id": "T146",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 44,
              "end_idx": 47,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T147",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 60,
              "end_idx": 64,
              "entity_en": "Metformin"
            },
            {
              "entity_id": "T148",
              "entity": "乳酸酸中毒",
              "entity_type": "ADE",
              "start_idx": 67,
              "end_idx": 72,
              "entity_en": "Lactic acidosis"
            },
            {
              "entity_id": "T149",
              "entity": "肾功能不全",
              "entity_type": "Disease",
              "start_idx": 76,
              "end_idx": 81,
              "entity_en": "Renal insufficiency"
            },
            {
              "entity_id": "T150",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 76,
              "end_idx": 77,
              "entity_en": "kidney"
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R46",
              "head_entity_id": "T142",
              "tail_entity_id": "T140"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R47",
              "head_entity_id": "T146",
              "tail_entity_id": "T143"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R48",
              "head_entity_id": "T145",
              "tail_entity_id": "T144"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R49",
              "head_entity_id": "T146",
              "tail_entity_id": "T144"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R50",
              "head_entity_id": "T148",
              "tail_entity_id": "T147"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R51",
              "head_entity_id": "T150",
              "tail_entity_id": "T149"
            }
          ],
          "sentence_en": "1. Diabetic patients should stop taking oral hypoglycemic drugs and non-insulin injections on the day of surgery. Sulfonylurea and glinide oral hypoglycemic drugs may cause hypoglycemia and should be discontinued at least 24 hours before surgery; metformin has the risk of causing lactic acidosis and should be discontinued 24 to 48 hours before surgery in patients with renal insufficiency."
        },
        {
          "sentence_id": "1",
          "sentence": "停药期间监测血糖，使用常规胰岛素控制血糖水平。",
          "start_idx": 94,
          "end_idx": 117,
          "entities": [
            {
              "entity_id": "T151",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 6,
              "end_idx": 8,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T152",
              "entity": "常规胰岛素",
              "entity_type": "Drug",
              "start_idx": 11,
              "end_idx": 16,
              "entity_en": "Regular insulin"
            },
            {
              "entity_id": "T153",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 18,
              "end_idx": 20,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Monitor blood sugar during the withdrawal period and use regular insulin to control blood sugar levels."
        },
        {
          "sentence_id": "2",
          "sentence": "术前住院时间超过3天的患者可在入院后即换用短效胰岛素皮下注射控制血糖，术前调整到适合的剂量。",
          "start_idx": 117,
          "end_idx": 163,
          "entities": [
            {
              "entity_id": "T154",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 26,
              "entity_en": "Short-acting insulin"
            },
            {
              "entity_id": "T155",
              "entity": "皮下注射",
              "entity_type": "Method",
              "start_idx": 26,
              "end_idx": 30,
              "entity_en": "Subcutaneous injection"
            },
            {
              "entity_id": "T156",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 32,
              "end_idx": 34,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R52",
              "head_entity_id": "T155",
              "tail_entity_id": "T154"
            }
          ],
          "sentence_en": "Patients whose preoperative hospitalization time exceeds 3 days can switch to subcutaneous injection of short-acting insulin to control blood sugar after admission, and adjust to the appropriate dose before surgery."
        },
        {
          "sentence_id": "3",
          "sentence": "无需禁食水的短小局麻手术可保留口服降糖药。",
          "start_idx": 163,
          "end_idx": 184,
          "entities": [
            {
              "entity_id": "T157",
              "entity": "禁食水",
              "entity_type": "Treatment",
              "start_idx": 2,
              "end_idx": 5,
              "entity_en": "Fasting water"
            },
            {
              "entity_id": "T158",
              "entity": "局麻手术",
              "entity_type": "Operation",
              "start_idx": 8,
              "end_idx": 12,
              "entity_en": "Surgery under local anesthesia"
            },
            {
              "entity_id": "T159",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 15,
              "end_idx": 17,
              "entity_en": "oral"
            }
          ],
          "relations": [],
          "sentence_en": "Short local anesthesia surgeries without fasting or water retention allow the retention of oral hypoglycemic drugs."
        }
      ],
      "paragraph_en": "1. Diabetic patients should stop taking oral hypoglycemic drugs and non-insulin injections on the day of surgery. Sulfonylurea and glinide oral hypoglycemic drugs may cause hypoglycemia and should be discontinued for at least 24 hours before surgery; metformin has the risk of causing lactic acidosis and should be discontinued for 24 to 48 hours before surgery in patients with renal insufficiency. Monitor blood sugar during the medication discontinuation period and use regular insulin to control blood sugar levels. Patients who are hospitalized for more than 3 days before surgery can switch to short-acting insulin subcutaneous injection to control blood sugar after admission, and adjust to the appropriate dose before surgery. Oral hypoglycemic drugs can be retained for short local anesthesia surgeries that do not require fasting or water."
    },
    {
      "paragraph_id": "16",
      "paragraph": "2.入院前长期胰岛素治疗者，方案多为控制基础血糖的中长效胰岛素联合控制餐后血糖的短效胰岛素皮下注射。长时间大手术、术后无法恢复进食的糖尿病患者，手术日换用短效胰岛素持续静脉泵注控制血糖。短小门诊手术者，手术当日可保留中长效胰岛素，剂量不变或减少1/3~1/2，停用餐前短效胰岛素。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.入院前长期胰岛素治疗者，方案多为控制基础血糖的中长效胰岛素联合控制餐后血糖的短效胰岛素皮下注射。长时间大手术、术后无法恢复进食的糖尿病患者，手术日换用短效胰岛素持续静脉泵注控制血糖。短小门诊手术者，手术当日可保留中长效胰岛素，剂量不变或减少1/3~1/2，停用餐前短效胰岛素。",
          "start_idx": 0,
          "end_idx": 140,
          "entities": [
            {
              "entity_id": "T160",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 10,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T161",
              "entity": "基础血糖",
              "entity_type": "Test_items",
              "start_idx": 20,
              "end_idx": 24,
              "entity_en": "Basal blood sugar"
            },
            {
              "entity_id": "T162",
              "entity": "中长效胰岛素",
              "entity_type": "Drug",
              "start_idx": 25,
              "end_idx": 31,
              "entity_en": "Intermediate- and long-acting insulin"
            },
            {
              "entity_id": "T163",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 35,
              "end_idx": 39,
              "entity_en": "Postprandial blood sugar"
            },
            {
              "entity_id": "T164",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 40,
              "end_idx": 45,
              "entity_en": "Short-acting insulin"
            },
            {
              "entity_id": "T165",
              "entity": "皮下注射",
              "entity_type": "Method",
              "start_idx": 45,
              "end_idx": 49,
              "entity_en": "Subcutaneous injection"
            },
            {
              "entity_id": "T166",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 66,
              "end_idx": 69,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T167",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 77,
              "end_idx": 82,
              "entity_en": "Short-acting insulin"
            },
            {
              "entity_id": "T168",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 82,
              "end_idx": 84,
              "entity_en": "continued"
            },
            {
              "entity_id": "T169",
              "entity": "静脉泵注",
              "entity_type": "Method",
              "start_idx": 84,
              "end_idx": 88,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T170",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 90,
              "end_idx": 92,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T171",
              "entity": "中长效胰岛素",
              "entity_type": "Drug",
              "start_idx": 108,
              "end_idx": 114,
              "entity_en": "Intermediate- and long-acting insulin"
            },
            {
              "entity_id": "T172",
              "entity": "剂量不变或减少1/3~1/2",
              "entity_type": "Amount",
              "start_idx": 115,
              "end_idx": 129,
              "entity_en": "The dose remains unchanged or is reduced by 1/3 to 1/2"
            },
            {
              "entity_id": "T173",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 134,
              "end_idx": 139,
              "entity_en": "Short-acting insulin"
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R53",
              "head_entity_id": "T165",
              "tail_entity_id": "T162"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R54",
              "head_entity_id": "T165",
              "tail_entity_id": "T164"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R55",
              "head_entity_id": "T170",
              "tail_entity_id": "T166"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R56",
              "head_entity_id": "T167",
              "tail_entity_id": "T166"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R57",
              "head_entity_id": "T168",
              "tail_entity_id": "T167"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R58",
              "head_entity_id": "T169",
              "tail_entity_id": "T167"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R59",
              "head_entity_id": "T172",
              "tail_entity_id": "T171"
            }
          ],
          "sentence_en": "2. For patients who have been receiving long-term insulin therapy before admission, the regimen is usually a combination of medium- and long-acting insulin to control basal blood sugar and short-acting insulin to control postprandial blood sugar. For diabetic patients who have undergone long-term major surgery and are unable to resume eating after surgery, short-acting insulin can be used for continuous intravenous infusion to control blood sugar on the day of surgery. For patients who have undergone short outpatient surgery, medium- and long-acting insulin can be retained on the day of surgery, with the dose remaining the same or reduced by 1/3 to 1/2, and short-acting insulin before meals can be stopped."
        }
      ],
      "paragraph_en": "2. For patients who have been receiving long-term insulin therapy before admission, the regimen is usually a combination of medium- and long-acting insulin to control basal blood sugar and short-acting insulin to control postprandial blood sugar. For diabetic patients who have undergone long-term major surgery and are unable to resume eating after surgery, short-acting insulin can be used for continuous intravenous infusion to control blood sugar on the day of surgery. For patients who have undergone short outpatient surgery, medium- and long-acting insulin can be retained on the day of surgery, with the dose remaining the same or reduced by 1/3 to 1/2, and short-acting insulin before meals can be stopped."
    },
    {
      "paragraph_id": "17",
      "paragraph": "3.术前控制餐前血糖≤140mg/dl(7.8mmol/L)，餐后血糖≤180mg/dl(10.0mmol/L)。手术风险越高，术前血糖控制达标的重要性越强。另一方面，术前血糖长期显著增高者，围术期血糖不宜下降过快。因此，应当综合评估风险，合理选择手术时机，可适当放宽术前血糖目标上限至空腹≤180mg/dl(10mmol/L)，随机或餐后2小时≤216mg/dl(12mmol/L)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.术前控制餐前血糖≤140mg/dl(7.8mmol/L)，餐后血糖≤180mg/dl(10.0mmol/L)。",
          "start_idx": 0,
          "end_idx": 57,
          "entities": [
            {
              "entity_id": "T174",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 6,
              "end_idx": 10,
              "entity_en": "Pre-meal blood sugar"
            },
            {
              "entity_id": "T175",
              "entity": "≤140mg/dl(7.8mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 10,
              "end_idx": 30,
              "entity_en": "≤140 mg/dL (7.8 mmol/L)"
            },
            {
              "entity_id": "T176",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 31,
              "end_idx": 35,
              "entity_en": "Postprandial blood sugar"
            },
            {
              "entity_id": "T177",
              "entity": "≤180mg/dl(10.0mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 35,
              "end_idx": 56,
              "entity_en": "≤180 mg/dL (10.0 mmol/L)"
            }
          ],
          "relations": [],
          "sentence_en": "3. Before surgery, control pre-meal blood sugar ≤140mg/dl (7.8mmol/L) and post-meal blood sugar ≤180mg/dl (10.0mmol/L)."
        },
        {
          "sentence_id": "1",
          "sentence": "手术风险越高，术前血糖控制达标的重要性越强。",
          "start_idx": 57,
          "end_idx": 79,
          "entities": [
            {
              "entity_id": "T178",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 9,
              "end_idx": 11,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "The higher the surgical risk, the more important it is to achieve target blood sugar levels before surgery."
        },
        {
          "sentence_id": "2",
          "sentence": "另一方面，术前血糖长期显著增高者，围术期血糖不宜下降过快。",
          "start_idx": 79,
          "end_idx": 108,
          "entities": [
            {
              "entity_id": "T179",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T180",
              "entity": "长期显著增高",
              "entity_type": "Test_Value",
              "start_idx": 9,
              "end_idx": 15,
              "entity_en": "Long-term significant increase"
            },
            {
              "entity_id": "T181",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 20,
              "end_idx": 22,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T187",
              "entity": "下降过快",
              "entity_type": "Test_Value",
              "start_idx": 24,
              "end_idx": 28,
              "entity_en": "Falling too fast"
            }
          ],
          "relations": [],
          "sentence_en": "On the other hand, for patients whose blood sugar level is significantly elevated for a long time before surgery, blood sugar level should not drop too quickly during the perioperative period."
        },
        {
          "sentence_id": "3",
          "sentence": "因此，应当综合评估风险，合理选择手术时机，可适当放宽术前血糖目标上限至空腹≤180mg/dl(10mmol/L)，随机或餐后2小时≤216mg/dl(12mmol/L)。",
          "start_idx": 108,
          "end_idx": 193,
          "entities": [
            {
              "entity_id": "T182",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 28,
              "end_idx": 30,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T183",
              "entity": "≤180mg/dl(10mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 37,
              "end_idx": 56,
              "entity_en": "≤180 mg/dl (10 mmol/L)"
            },
            {
              "entity_id": "T184",
              "entity": "随机或餐后2小时",
              "entity_type": "Test_items",
              "start_idx": 57,
              "end_idx": 65,
              "entity_en": "Randomly or 2 hours after meal"
            },
            {
              "entity_id": "T185",
              "entity": "≤216mg/dl(12mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 65,
              "end_idx": 84,
              "entity_en": "≤216 mg/dL (12 mmol/L)"
            },
            {
              "entity_id": "T186",
              "entity": "空腹",
              "entity_type": "Test_items",
              "start_idx": 35,
              "end_idx": 37,
              "entity_en": "Fasting"
            }
          ],
          "relations": [],
          "sentence_en": "Therefore, the risks should be comprehensively assessed and the timing of surgery should be reasonably selected. The upper limit of the preoperative blood glucose target can be appropriately relaxed to fasting ≤180 mg/dl (10 mmol/L) and random or 2 hours after a meal ≤216 mg/dl (12 mmol/L)."
        }
      ],
      "paragraph_en": "3. Preoperatively, control pre-meal blood sugar ≤140mg/dl (7.8mmol/L), and post-meal blood sugar ≤180mg/dl (10.0mmol/L). The higher the surgical risk, the more important it is to achieve preoperative blood sugar control. On the other hand, for patients with long-term and significant preoperative blood sugar elevation, perioperative blood sugar should not drop too quickly. Therefore, the risks should be comprehensively assessed and the timing of surgery should be reasonably selected. The upper limit of the preoperative blood sugar target can be appropriately relaxed to fasting ≤180mg/dl (10mmol/L), and random or 2 hours after a meal ≤216mg/dl (12mmol/L)."
    },
    {
      "paragraph_id": "18",
      "paragraph": "4.避免术前不必要的长时间禁食，糖尿病患者择期手术应安排在当日第一台进行。禁食期间注意血糖监测，必要时输注含糖液体。由于术前精神紧张应激，手术患者发生低血糖的风险低于普通住院患者。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4.避免术前不必要的长时间禁食，糖尿病患者择期手术应安排在当日第一台进行。禁食期间注意血糖监测，必要时输注含糖液体。由于术前精神紧张应激，手术患者发生低血糖的风险低于普通住院患者。",
          "start_idx": 0,
          "end_idx": 90,
          "entities": [
            {
              "entity_id": "T188",
              "entity": "禁食",
              "entity_type": "Treatment",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "fasting"
            },
            {
              "entity_id": "T189",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 16,
              "end_idx": 19,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T190",
              "entity": "禁食",
              "entity_type": "Treatment",
              "start_idx": 37,
              "end_idx": 39,
              "entity_en": "fasting"
            },
            {
              "entity_id": "T191",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 43,
              "end_idx": 45,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T192",
              "entity": "输注",
              "entity_type": "Method",
              "start_idx": 51,
              "end_idx": 53,
              "entity_en": "Infusion"
            },
            {
              "entity_id": "T193",
              "entity": "含糖液体",
              "entity_type": "Drug",
              "start_idx": 53,
              "end_idx": 57,
              "entity_en": "Sugary liquids"
            },
            {
              "entity_id": "T194",
              "entity": "精神紧张应激",
              "entity_type": "Reason",
              "start_idx": 62,
              "end_idx": 68,
              "entity_en": "Mental stress"
            },
            {
              "entity_id": "T195",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 75,
              "end_idx": 78,
              "entity_en": "Hypoglycemia"
            }
          ],
          "relations": [
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R60",
              "head_entity_id": "T188",
              "tail_entity_id": "T189"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R61",
              "head_entity_id": "T192",
              "tail_entity_id": "T193"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R62",
              "head_entity_id": "T194",
              "tail_entity_id": "T195"
            }
          ],
          "sentence_en": "4. Avoid unnecessary long-term fasting before surgery. Elective surgery for diabetic patients should be scheduled as the first surgery of the day. Pay attention to blood sugar monitoring during fasting and infuse sugar-containing fluids when necessary. Due to preoperative mental stress, the risk of hypoglycemia in surgical patients is lower than that of ordinary inpatients."
        }
      ],
      "paragraph_en": "4. Avoid unnecessary long-term fasting before surgery. Elective surgery for diabetic patients should be scheduled as the first surgery of the day. Pay attention to blood sugar monitoring during fasting and infuse sugar-containing fluids when necessary. Due to preoperative mental stress, the risk of hypoglycemia in surgical patients is lower than that of ordinary inpatients."
    },
    {
      "paragraph_id": "19",
      "paragraph": "围术期血糖监测和控制目标",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "围术期血糖监测和控制目标",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T196",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Perioperative blood glucose monitoring and control targets"
        }
      ],
      "paragraph_en": "Perioperative blood glucose monitoring and control targets"
    },
    {
      "paragraph_id": "20",
      "paragraph": "围术期血糖测量方法床旁快速血糖仪测量指血(毛细血管血)血糖用于血流动力学稳定的患者。血糖仪需定期校准。严重低血糖时血糖仪所测得的数值可能偏高，应与中心实验室测量的静脉血结果进行对照。动脉或静脉血气分析是围术期血糖监测的金标准。在低血压、组织低灌注、贫血以及高血脂、高胆红素血症等代谢异常的情况下，指血血糖准确性下降，应使用动脉血气监测血糖。生理情况下，动脉血糖较毛细血管血糖高0.3mmol/L。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "围术期血糖测量方法床旁快速血糖仪测量指血(毛细血管血)血糖用于血流动力学稳定的患者。血糖仪需定期校准。严重低血糖时血糖仪所测得的数值可能偏高，应与中心实验室测量的静脉血结果进行对照。动脉或静脉血气分析是围术期血糖监测的金标准。在低血压、组织低灌注、贫血以及高血脂、高胆红素血症等代谢异常的情况下，指血血糖准确性下降，应使用动脉血气监测血糖。",
          "start_idx": 0,
          "end_idx": 170,
          "entities": [
            {
              "entity_id": "T197",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T198",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T199",
              "entity": "指血(毛细血管血)血糖",
              "entity_type": "Test_items",
              "start_idx": 18,
              "end_idx": 29,
              "entity_en": "Finger blood (capillary blood) blood sugar"
            },
            {
              "entity_id": "T200",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 42,
              "end_idx": 44,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T203",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 51,
              "end_idx": 53,
              "entity_en": "serious"
            },
            {
              "entity_id": "T204",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 167,
              "end_idx": 169,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T205",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 53,
              "end_idx": 56,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T206",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 57,
              "end_idx": 59,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T207",
              "entity": "偏高",
              "entity_type": "Test_Value",
              "start_idx": 68,
              "end_idx": 70,
              "entity_en": "High"
            },
            {
              "entity_id": "T208",
              "entity": "动脉或静脉血气分析",
              "entity_type": "Test",
              "start_idx": 91,
              "end_idx": 100,
              "entity_en": "Arterial or venous blood gas analysis"
            },
            {
              "entity_id": "T209",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 104,
              "end_idx": 106,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T210",
              "entity": "低血压",
              "entity_type": "Symptom",
              "start_idx": 114,
              "end_idx": 117,
              "entity_en": "Low blood pressure"
            },
            {
              "entity_id": "T211",
              "entity": "组织低灌注",
              "entity_type": "Symptom",
              "start_idx": 118,
              "end_idx": 123,
              "entity_en": "Tissue hypoperfusion"
            },
            {
              "entity_id": "T212",
              "entity": "贫血",
              "entity_type": "Disease",
              "start_idx": 124,
              "end_idx": 126,
              "entity_en": "anemia"
            },
            {
              "entity_id": "T213",
              "entity": "高血脂",
              "entity_type": "Disease",
              "start_idx": 128,
              "end_idx": 131,
              "entity_en": "High cholesterol"
            },
            {
              "entity_id": "T214",
              "entity": "高胆红素血症",
              "entity_type": "Disease",
              "start_idx": 132,
              "end_idx": 138,
              "entity_en": "Hyperbilirubinemia"
            },
            {
              "entity_id": "T215",
              "entity": "指血血糖",
              "entity_type": "Test_items",
              "start_idx": 148,
              "end_idx": 152,
              "entity_en": "Blood glucose"
            },
            {
              "entity_id": "T216",
              "entity": "准确性下降",
              "entity_type": "Test_Value",
              "start_idx": 152,
              "end_idx": 157,
              "entity_en": "Decreased accuracy"
            },
            {
              "entity_id": "T217",
              "entity": "动脉血气",
              "entity_type": "Test",
              "start_idx": 161,
              "end_idx": 165,
              "entity_en": "Arterial blood gas"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R63",
              "head_entity_id": "T204",
              "tail_entity_id": "T212"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R64",
              "head_entity_id": "T204",
              "tail_entity_id": "T213"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R65",
              "head_entity_id": "T204",
              "tail_entity_id": "T214"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R66",
              "head_entity_id": "T206",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R67",
              "head_entity_id": "T215",
              "tail_entity_id": "T212"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R68",
              "head_entity_id": "T217",
              "tail_entity_id": "T212"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R69",
              "head_entity_id": "T215",
              "tail_entity_id": "T213"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R70",
              "head_entity_id": "T217",
              "tail_entity_id": "T213"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R71",
              "head_entity_id": "T215",
              "tail_entity_id": "T214"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R72",
              "head_entity_id": "T217",
              "tail_entity_id": "T214"
            }
          ],
          "sentence_en": "Methods for perioperative blood glucose measurement: The bedside rapid blood glucose meter measures finger blood (capillary blood) blood glucose for patients with stable hemodynamics. The blood glucose meter needs to be calibrated regularly. In severe hypoglycemia, the value measured by the blood glucose meter may be too high and should be compared with the venous blood results measured by the central laboratory. Arterial or venous blood gas analysis is the gold standard for perioperative blood glucose monitoring. In the case of hypotension, tissue hypoperfusion, anemia, hyperlipidemia, hyperbilirubinemia and other metabolic abnormalities, the accuracy of finger blood glucose decreases, and arterial blood gas should be used to monitor blood glucose."
        },
        {
          "sentence_id": "1",
          "sentence": "生理情况下，动脉血糖较毛细血管血糖高0.3mmol/L。",
          "start_idx": 170,
          "end_idx": 198,
          "entities": [
            {
              "entity_id": "T201",
              "entity": "动脉血糖",
              "entity_type": "Test_items",
              "start_idx": 6,
              "end_idx": 10,
              "entity_en": "Arterial blood glucose"
            },
            {
              "entity_id": "T202",
              "entity": "毛细血管血糖",
              "entity_type": "Test_items",
              "start_idx": 11,
              "end_idx": 17,
              "entity_en": "Capillary blood glucose"
            },
            {
              "entity_id": "T218",
              "entity": "高0.3mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 17,
              "end_idx": 27,
              "entity_en": "High 0.3mmol/L"
            }
          ],
          "relations": [],
          "sentence_en": "Under physiological conditions, arterial blood glucose is 0.3mmol/L higher than capillary blood glucose."
        }
      ],
      "paragraph_en": "Perioperative blood glucose measurement method: The bedside rapid blood glucose meter measures finger blood (capillary blood) blood glucose for patients with stable hemodynamics. The blood glucose meter needs to be calibrated regularly. In severe hypoglycemia, the value measured by the blood glucose meter may be too high and should be compared with the venous blood results measured by the central laboratory. Arterial or venous blood gas analysis is the gold standard for perioperative blood glucose monitoring. In the case of hypotension, tissue hypoperfusion, anemia, hyperlipidemia, hyperbilirubinemia and other metabolic abnormalities, the accuracy of finger blood glucose decreases, and arterial blood gas should be used to monitor blood glucose. Under physiological conditions, arterial blood glucose is 0.3mmol/L higher than capillary blood glucose."
    },
    {
      "paragraph_id": "21",
      "paragraph": "围术期血糖监测频率正常饮食的患者监测空腹血糖、三餐后血糖和睡前血糖。禁食患者每4~6小时监测一次血糖。术中血糖波动风险高，低血糖表现难以发现，应1~2小时监测一次血糖。危重患者、大手术或持续静脉输注胰岛素的患者，每0.5~1小时监测一次。体外循环手术中，降温复温期间血糖波动大，每15分钟监测一次。血糖≤70mg/dl(3.9mmol/L)时每5~15分钟监测一次直至低血糖得到纠正。病情稳定的门诊手术患者，如手术时间≤2小时，在入院后和离院前分别监测一次血糖。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "围术期血糖监测频率正常饮食的患者监测空腹血糖、三餐后血糖和睡前血糖。禁食患者每4~6小时监测一次血糖。术中血糖波动风险高，低血糖表现难以发现，应1~2小时监测一次血糖。危重患者、大手术或持续静脉输注胰岛素的患者，每0.5~1小时监测一次。体外循环手术中，降温复温期间血糖波动大，每15分钟监测一次。血糖≤70mg/dl(3.9mmol/L)时每5~15分钟监测一次直至低血糖得到纠正。",
          "start_idx": 0,
          "end_idx": 192,
          "entities": [
            {
              "entity_id": "T219",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T220",
              "entity": "空腹血糖",
              "entity_type": "Test_items",
              "start_idx": 18,
              "end_idx": 22,
              "entity_en": "Fasting blood sugar"
            },
            {
              "entity_id": "T221",
              "entity": "三餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 23,
              "end_idx": 28,
              "entity_en": "Blood sugar after three meals"
            },
            {
              "entity_id": "T222",
              "entity": "睡前血糖",
              "entity_type": "Test_items",
              "start_idx": 29,
              "end_idx": 33,
              "entity_en": "Blood sugar before bed"
            },
            {
              "entity_id": "T223",
              "entity": "禁食",
              "entity_type": "Treatment",
              "start_idx": 34,
              "end_idx": 36,
              "entity_en": "fasting"
            },
            {
              "entity_id": "T224",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 48,
              "end_idx": 50,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T225",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 53,
              "end_idx": 55,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T226",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 55,
              "end_idx": 57,
              "entity_en": "fluctuation"
            },
            {
              "entity_id": "T227",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 61,
              "end_idx": 64,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T228",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 81,
              "end_idx": 83,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T229",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 93,
              "end_idx": 95,
              "entity_en": "continued"
            },
            {
              "entity_id": "T230",
              "entity": "静脉输注",
              "entity_type": "Method",
              "start_idx": 95,
              "end_idx": 99,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T231",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 99,
              "end_idx": 102,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T232",
              "entity": "体外循环手术",
              "entity_type": "Operation",
              "start_idx": 119,
              "end_idx": 125,
              "entity_en": "Extracorporeal circulation surgery"
            },
            {
              "entity_id": "T233",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 133,
              "end_idx": 135,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T234",
              "entity": "波动大",
              "entity_type": "Test_Value",
              "start_idx": 135,
              "end_idx": 138,
              "entity_en": "Large fluctuations"
            },
            {
              "entity_id": "T235",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 149,
              "end_idx": 151,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T236",
              "entity": "≤70mg/dl(3.9mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 151,
              "end_idx": 170,
              "entity_en": "≤70 mg/dL (3.9 mmol/L)"
            },
            {
              "entity_id": "T237",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 184,
              "end_idx": 187,
              "entity_en": "Hypoglycemia"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R73",
              "head_entity_id": "T225",
              "tail_entity_id": "T227"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R74",
              "head_entity_id": "T228",
              "tail_entity_id": "T227"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R75",
              "head_entity_id": "T229",
              "tail_entity_id": "T231"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R76",
              "head_entity_id": "T230",
              "tail_entity_id": "T231"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R77",
              "head_entity_id": "T235",
              "tail_entity_id": "T237"
            }
          ],
          "sentence_en": "Frequency of perioperative blood glucose monitoring: Patients with a normal diet should monitor fasting blood glucose, blood glucose after three meals, and blood glucose before bed. Fasting patients should monitor blood glucose every 4 to 6 hours. The risk of intraoperative blood glucose fluctuations is high, and hypoglycemia is difficult to detect, so blood glucose should be monitored every 1 to 2 hours. Critically ill patients, patients undergoing major surgery, or patients receiving continuous intravenous insulin infusion should be monitored every 0.5 to 1 hour. During extracorporeal circulation surgery, blood glucose fluctuates greatly during cooling and rewarming, and should be monitored every 15 minutes. When blood glucose is ≤70 mg/dl (3.9 mmol/L), monitor every 5 to 15 minutes until hypoglycemia is corrected."
        },
        {
          "sentence_id": "1",
          "sentence": "病情稳定的门诊手术患者，如手术时间≤2小时，在入院后和离院前分别监测一次血糖。",
          "start_idx": 192,
          "end_idx": 231,
          "entities": [
            {
              "entity_id": "T238",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 36,
              "end_idx": 38,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "For patients undergoing outpatient surgery who are in stable condition and whose surgery time is ≤2 hours, their blood sugar should be monitored once after admission and before discharge."
        }
      ],
      "paragraph_en": "Frequency of perioperative blood glucose monitoring: Patients with a normal diet should monitor fasting blood glucose, blood glucose after three meals, and blood glucose before bed. Fasting patients should monitor blood glucose every 4 to 6 hours. The risk of intraoperative blood glucose fluctuations is high, and hypoglycemia is difficult to detect, so blood glucose should be monitored every 1 to 2 hours. For critically ill patients, patients undergoing major surgery, or patients receiving continuous intravenous insulin infusion, monitor every 0.5 to 1 hour. During extracorporeal circulation surgery, blood glucose fluctuates greatly during cooling and rewarming, and should be monitored every 15 minutes. When blood glucose is ≤70 mg/dl (3.9 mmol/L), monitor every 5 to 15 minutes until hypoglycemia is corrected. For outpatient surgery patients with stable conditions, if the operation time is ≤2 hours, monitor blood glucose once after admission and before discharge."
    },
    {
      "paragraph_id": "22",
      "paragraph": "围术期血糖控制目标",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "围术期血糖控制目标",
          "start_idx": 0,
          "end_idx": 9,
          "entities": [
            {
              "entity_id": "T239",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Perioperative blood sugar control target"
        }
      ],
      "paragraph_en": "Perioperative blood sugar control target"
    },
    {
      "paragraph_id": "23",
      "paragraph": "1.推荐围术期血糖控制在140mg/dl(7.8mmol/L)~180mg/dl(10.0mmol/L)，不建议控制过严。正常饮食的患者控制餐前血糖≤140mg/dl(7.8mmol/L)，餐后血糖≤180mg/dl(10.0mmol/L)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.推荐围术期血糖控制在140mg/dl(7.8mmol/L)~180mg/dl(10.0mmol/L)，不建议控制过严。",
          "start_idx": 0,
          "end_idx": 61,
          "entities": [
            {
              "entity_id": "T240",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T241",
              "entity": "140mg/dl(7.8mmol/L)~180mg/dl(10.0mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 12,
              "end_idx": 52,
              "entity_en": "140mg/dl(7.8mmol/L)~180mg/dl(10.0mmol/L)"
            }
          ],
          "relations": [],
          "sentence_en": "1. It is recommended that perioperative blood sugar be controlled at 140 mg/dl (7.8 mmol/L) ~ 180 mg/dl (10.0 mmol/L). Too strict control is not recommended."
        },
        {
          "sentence_id": "1",
          "sentence": "正常饮食的患者控制餐前血糖≤140mg/dl(7.8mmol/L)，餐后血糖≤180mg/dl(10.0mmol/L)。",
          "start_idx": 61,
          "end_idx": 121,
          "entities": [
            {
              "entity_id": "T242",
              "entity": "餐前血糖",
              "entity_type": "Test_items",
              "start_idx": 9,
              "end_idx": 13,
              "entity_en": "Pre-meal blood sugar"
            },
            {
              "entity_id": "T243",
              "entity": "≤140mg/dl(7.8mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 13,
              "end_idx": 33,
              "entity_en": "≤140 mg/dL (7.8 mmol/L)"
            },
            {
              "entity_id": "T244",
              "entity": "餐后血糖",
              "entity_type": "Test_items",
              "start_idx": 34,
              "end_idx": 38,
              "entity_en": "Postprandial blood sugar"
            },
            {
              "entity_id": "T245",
              "entity": "≤180mg/dl(10.0mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 38,
              "end_idx": 59,
              "entity_en": "≤180 mg/dL (10.0 mmol/L)"
            }
          ],
          "relations": [],
          "sentence_en": "For patients with a normal diet, pre-meal blood sugar should be controlled at ≤140mg/dl (7.8mmol/L) and post-meal blood sugar at ≤180mg/dl (10.0mmol/L)."
        }
      ],
      "paragraph_en": "1. It is recommended that perioperative blood sugar be controlled at 140mg/dl (7.8mmol/L)~180mg/dl (10.0mmol/L). Too strict control is not recommended. For patients with a normal diet, pre-meal blood sugar should be controlled to ≤140mg/dl (7.8mmol/L) and post-meal blood sugar to ≤180mg/dl (10.0mmol/L)."
    },
    {
      "paragraph_id": "24",
      "paragraph": "2.术后ICU住院时间≥3d的危重患者，推荐血糖目标值≤150mg/dl(8.4mmol/L)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.术后ICU住院时间≥3d的危重患者，推荐血糖目标值≤150mg/dl(8.4mmol/L)。",
          "start_idx": 0,
          "end_idx": 48,
          "entities": [
            {
              "entity_id": "T246",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 22,
              "end_idx": 24,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T247",
              "entity": "≤150mg/dl(8.4mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 27,
              "end_idx": 47,
              "entity_en": "≤150 mg/dL (8.4 mmol/L)"
            }
          ],
          "relations": [],
          "sentence_en": "2. For critically ill patients with postoperative ICU stay of ≥3 days, the recommended blood glucose target value is ≤150 mg/dl (8.4 mmol/L)."
        }
      ],
      "paragraph_en": "2. For critically ill patients with postoperative ICU stay of ≥3 days, the recommended blood glucose target value is ≤150 mg/dl (8.4 mmol/L)."
    },
    {
      "paragraph_id": "25",
      "paragraph": "3.根据患者手术类型、术前血糖水平、脏器功能，建立围术期血糖控制的个体化目标。整形手术对伤口愈合要求高，血糖目标降低至108mg/dl(6.0mmol/L)~144mg/dl(8.0mmol/L)有利于减少术后伤口感染。脑血管疾病患者对低血糖耐受差，血糖目标值可适当放宽至≤214mg/dl(12.0mmol/L)。高龄、有严重合并症、频繁发作低血糖的患者，血糖目标值也可适当放宽。原则上血糖最高不宜超过250mg/dl(13.9mmol/L)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.根据患者手术类型、术前血糖水平、脏器功能，建立围术期血糖控制的个体化目标。整形手术对伤口愈合要求高，血糖目标降低至108mg/dl(6.0mmol/L)~144mg/dl(8.0mmol/L)有利于减少术后伤口感染。脑血管疾病患者对低血糖耐受差，血糖目标值可适当放宽至≤214mg/dl(12.0mmol/L)。",
          "start_idx": 0,
          "end_idx": 158,
          "entities": [
            {
              "entity_id": "T248",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T249",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 28,
              "end_idx": 30,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T250",
              "entity": "整形手术",
              "entity_type": "Operation",
              "start_idx": 39,
              "end_idx": 43,
              "entity_en": "Plastic surgery"
            },
            {
              "entity_id": "T251",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 52,
              "end_idx": 54,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T252",
              "entity": "108mg/dl(6.0mmol/L)~144mg/dl(8.0mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 59,
              "end_idx": 98,
              "entity_en": "108mg/dl(6.0mmol/L)~144mg/dl(8.0mmol/L)"
            },
            {
              "entity_id": "T253",
              "entity": "伤口感染",
              "entity_type": "ADE",
              "start_idx": 105,
              "end_idx": 109,
              "entity_en": "Wound infection"
            },
            {
              "entity_id": "T254",
              "entity": "脑血管疾病",
              "entity_type": "Disease",
              "start_idx": 110,
              "end_idx": 115,
              "entity_en": "Cerebrovascular disease"
            },
            {
              "entity_id": "T255",
              "entity": "脑血管",
              "entity_type": "Anatomy",
              "start_idx": 110,
              "end_idx": 113,
              "entity_en": "Cerebrovascular"
            },
            {
              "entity_id": "T256",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 118,
              "end_idx": 121,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T257",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 125,
              "end_idx": 127,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T258",
              "entity": "≤214mg/dl(12.0mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 136,
              "end_idx": 157,
              "entity_en": "≤214 mg/dL (12.0 mmol/L)"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R78",
              "head_entity_id": "T255",
              "tail_entity_id": "T254"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R79",
              "head_entity_id": "T257",
              "tail_entity_id": "T254"
            }
          ],
          "sentence_en": "3. Establish individualized goals for perioperative blood sugar control based on the type of surgery, preoperative blood sugar level, and organ function. Plastic surgery requires high wound healing, and lowering the blood sugar target to 108mg/dl (6.0mmol/L)~144mg/dl (8.0mmol/L) is beneficial to reduce postoperative wound infection. Patients with cerebrovascular disease have poor tolerance to hypoglycemia, and the blood sugar target value can be appropriately relaxed to ≤214mg/dl (12.0mmol/L)."
        },
        {
          "sentence_id": "1",
          "sentence": "高龄、有严重合并症、频繁发作低血糖的患者，血糖目标值也可适当放宽。",
          "start_idx": 158,
          "end_idx": 191,
          "entities": [
            {
              "entity_id": "T259",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 14,
              "end_idx": 17,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T260",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 21,
              "end_idx": 23,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R80",
              "head_entity_id": "T260",
              "tail_entity_id": "T259"
            }
          ],
          "sentence_en": "For elderly patients, patients with severe comorbidities, and patients with frequent hypoglycemia, the blood sugar target value may be appropriately relaxed."
        },
        {
          "sentence_id": "2",
          "sentence": "原则上血糖最高不宜超过250mg/dl(13.9mmol/L)。",
          "start_idx": 191,
          "end_idx": 223,
          "entities": [
            {
              "entity_id": "T261",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T262",
              "entity": "最高不宜超过250mg/dl(13.9mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 5,
              "end_idx": 31,
              "entity_en": "The maximum should not exceed 250mg/dl (13.9mmol/L)"
            }
          ],
          "relations": [],
          "sentence_en": "In principle, the maximum blood sugar level should not exceed 250 mg/dl (13.9 mmol/L)."
        }
      ],
      "paragraph_en": "3. Establish individualized goals for perioperative blood sugar control based on the patient's surgery type, preoperative blood sugar level, and organ function. Plastic surgery has high requirements for wound healing, and lowering the blood sugar target to 108mg/dl (6.0mmol/L)~144mg/dl (8.0mmol/L) is beneficial to reduce postoperative wound infection. Patients with cerebrovascular disease have poor tolerance to hypoglycemia, and the blood sugar target value can be appropriately relaxed to ≤214mg/dl (12.0mmol/L). For elderly patients, patients with serious comorbidities, and patients with frequent hypoglycemia, the blood sugar target value can also be appropriately relaxed. In principle, the maximum blood sugar level should not exceed 250mg/dl (13.9mmol/L)."
    },
    {
      "paragraph_id": "26",
      "paragraph": "血糖管理实施方案",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "血糖管理实施方案",
          "start_idx": 0,
          "end_idx": 8,
          "entities": [
            {
              "entity_id": "T263",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Blood sugar management implementation plan"
        }
      ],
      "paragraph_en": "Blood sugar management implementation plan"
    },
    {
      "paragraph_id": "27",
      "paragraph": "高血糖",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "高血糖",
          "start_idx": 0,
          "end_idx": 3,
          "entities": [
            {
              "entity_id": "T264",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 3,
              "entity_en": "High blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "High blood sugar"
        }
      ],
      "paragraph_en": "High blood sugar"
    },
    {
      "paragraph_id": "28",
      "paragraph": "1.糖尿病患者围术期需要输注葡萄糖者，建议液体中按糖(g)：胰岛素(U)=3~4：1的比例加用胰岛素中和。肠内外营养的患者应注意营养液中的糖负荷，选用糖尿病专用型制剂，适当降低糖与脂肪的比例，缓慢输注，通过降低糖类总量、减慢吸收速度，降低血糖峰值，减少血糖波动。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.糖尿病患者围术期需要输注葡萄糖者，建议液体中按糖(g)：胰岛素(U)=3~4：1的比例加用胰岛素中和。肠内外营养的患者应注意营养液中的糖负荷，选用糖尿病专用型制剂，适当降低糖与脂肪的比例，缓慢输注，通过降低糖类总量、减慢吸收速度，降低血糖峰值，减少血糖波动。",
          "start_idx": 0,
          "end_idx": 131,
          "entities": [
            {
              "entity_id": "T265",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 5,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T266",
              "entity": "输注",
              "entity_type": "Method",
              "start_idx": 12,
              "end_idx": 14,
              "entity_en": "Infusion"
            },
            {
              "entity_id": "T267",
              "entity": "葡萄糖",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 17,
              "entity_en": "glucose"
            },
            {
              "entity_id": "T268",
              "entity": "糖(g)：胰岛素(U)",
              "entity_type": "Drug",
              "start_idx": 25,
              "end_idx": 36,
              "entity_en": "Sugar (g): Insulin (U)"
            },
            {
              "entity_id": "T269",
              "entity": "3~4：1",
              "entity_type": "Amount",
              "start_idx": 37,
              "end_idx": 42,
              "entity_en": "3~4:1"
            },
            {
              "entity_id": "T270",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 47,
              "end_idx": 50,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T271",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 75,
              "end_idx": 78,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T272",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 119,
              "end_idx": 121,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T273",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 126,
              "end_idx": 128,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T274",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 128,
              "end_idx": 130,
              "entity_en": "fluctuation"
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R81",
              "head_entity_id": "T267",
              "tail_entity_id": "T265"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R82",
              "head_entity_id": "T266",
              "tail_entity_id": "T267"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R83",
              "head_entity_id": "T269",
              "tail_entity_id": "T268"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R84",
              "head_entity_id": "T272",
              "tail_entity_id": "T271"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R85",
              "head_entity_id": "T273",
              "tail_entity_id": "T271"
            }
          ],
          "sentence_en": "1. For diabetic patients who need glucose infusion during the perioperative period, it is recommended to add insulin to the liquid at a ratio of sugar (g): insulin (U) = 3~4:1 to neutralize. Patients receiving enteral nutrition should pay attention to the sugar load in the nutrient solution, choose diabetes-specific preparations, appropriately reduce the ratio of sugar to fat, and infuse slowly, so as to reduce the total amount of sugar, slow down the absorption rate, reduce blood sugar peaks, and reduce blood sugar fluctuations."
        }
      ],
      "paragraph_en": "1. For diabetic patients who need to infuse glucose during the perioperative period, it is recommended to add insulin to the liquid at a ratio of sugar (g): insulin (U) = 3~4:1 to neutralize. Patients receiving enteral nutrition should pay attention to the sugar load in the nutrient solution, choose special preparations for diabetes, appropriately reduce the ratio of sugar to fat, and infuse slowly, so as to reduce the total amount of sugar, slow down the absorption rate, reduce the blood sugar peak, and reduce blood sugar fluctuations."
    },
    {
      "paragraph_id": "29",
      "paragraph": "2.尽量避免引起血糖升高的其他因素。地塞米松常用于预防术后恶心呕吐，可升高血糖水平。使用其他糖皮质激素、儿茶酚胺类药物、生长抑素和免疫抑制剂也可能造成血糖增高。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.尽量避免引起血糖升高的其他因素。",
          "start_idx": 0,
          "end_idx": 18,
          "entities": [
            {
              "entity_id": "T275",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 8,
              "end_idx": 10,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T276",
              "entity": "升高",
              "entity_type": "Test_Value",
              "start_idx": 10,
              "end_idx": 12,
              "entity_en": "Elevated"
            }
          ],
          "relations": [],
          "sentence_en": "2. Try to avoid other factors that cause high blood sugar."
        },
        {
          "sentence_id": "1",
          "sentence": "地塞米松常用于预防术后恶心呕吐，可升高血糖水平。",
          "start_idx": 18,
          "end_idx": 42,
          "entities": [
            {
              "entity_id": "T277",
              "entity": "地塞米松",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Dexamethasone"
            },
            {
              "entity_id": "T278",
              "entity": "恶心",
              "entity_type": "ADE",
              "start_idx": 11,
              "end_idx": 13,
              "entity_en": "nausea"
            },
            {
              "entity_id": "T279",
              "entity": "呕吐",
              "entity_type": "ADE",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "Vomit"
            },
            {
              "entity_id": "T280",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 19,
              "end_idx": 21,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Dexamethasone, which is often used to prevent postoperative nausea and vomiting, can increase blood sugar levels."
        },
        {
          "sentence_id": "2",
          "sentence": "使用其他糖皮质激素、儿茶酚胺类药物、生长抑素和免疫抑制剂也可能造成血糖增高。",
          "start_idx": 42,
          "end_idx": 80,
          "entities": [
            {
              "entity_id": "T281",
              "entity": "糖皮质激素",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 9,
              "entity_en": "Glucocorticoids"
            },
            {
              "entity_id": "T282",
              "entity": "儿茶酚胺类药物",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 17,
              "entity_en": "Catecholamines"
            },
            {
              "entity_id": "T283",
              "entity": "生长抑素",
              "entity_type": "Drug",
              "start_idx": 18,
              "end_idx": 22,
              "entity_en": "Somatostatin"
            },
            {
              "entity_id": "T284",
              "entity": "免疫抑制剂",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 28,
              "entity_en": "Immunosuppressants"
            },
            {
              "entity_id": "T285",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 33,
              "end_idx": 35,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T286",
              "entity": "增高",
              "entity_type": "Test_Value",
              "start_idx": 35,
              "end_idx": 37,
              "entity_en": "Increase"
            }
          ],
          "relations": [],
          "sentence_en": "The use of other glucocorticoids, catecholamines, somatostatin, and immunosuppressants may also cause hyperglycemia."
        }
      ],
      "paragraph_en": "2. Try to avoid other factors that cause blood sugar to rise. Dexamethasone is often used to prevent postoperative nausea and vomiting, which can increase blood sugar levels. The use of other glucocorticoids, catecholamines, somatostatin and immunosuppressants may also cause blood sugar to rise."
    },
    {
      "paragraph_id": "30",
      "paragraph": "3.血糖>180mg/dl(10.0mmol/L)开始胰岛素治疗。静脉给胰岛素起效快，方便滴定剂量，术中和术后ICU期间适宜静脉给药。持续静脉泵注胰岛素有利于减少血糖波动，糖尿病患者以及术前已经使用静脉胰岛素的患者术中首选持续静脉泵注胰岛素。应激性高血糖的患者可选择单次或间断静脉推注胰岛素，如血糖仍高，则予持续泵注。通常使用短效胰岛素加入生理盐水，浓度1U/ml配泵，参照患者的血糖水平、术前胰岛素用量、手术刺激大小等因素来确定胰岛素的用量，密切监测，根据血糖升降适当调整泵速，注意个体化给药，避免发生低血糖。胰岛素皮下注射适合病情稳定的非重症患者，常用于术前术后过渡；注意避免短时问内反复给药造成降糖药效叠加。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.血糖>180mg/dl(10.0mmol/L)开始胰岛素治疗。静脉给胰岛素起效快，方便滴定剂量，术中和术后ICU期间适宜静脉给药。持续静脉泵注胰岛素有利于减少血糖波动，糖尿病患者以及术前已经使用静脉胰岛素的患者术中首选持续静脉泵注胰岛素。应激性高血糖的患者可选择单次或间断静脉推注胰岛素，如血糖仍高，则予持续泵注。通常使用短效胰岛素加入生理盐水，浓度1U/ml配泵，参照患者的血糖水平、术前胰岛素用量、手术刺激大小等因素来确定胰岛素的用量，密切监测，根据血糖升降适当调整泵速，注意个体化给药，避免发生低血糖。",
          "start_idx": 0,
          "end_idx": 256,
          "entities": [
            {
              "entity_id": "T287",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 2,
              "end_idx": 4,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T288",
              "entity": ">180mg/dl(10.0mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 4,
              "end_idx": 25,
              "entity_en": ">180 mg/dL (10.0 mmol/L)"
            },
            {
              "entity_id": "T289",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 27,
              "end_idx": 30,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T290",
              "entity": "静脉",
              "entity_type": "Method",
              "start_idx": 33,
              "end_idx": 35,
              "entity_en": "vein"
            },
            {
              "entity_id": "T291",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 36,
              "end_idx": 39,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T292",
              "entity": "静脉给药",
              "entity_type": "Method",
              "start_idx": 62,
              "end_idx": 66,
              "entity_en": "Intravenous administration"
            },
            {
              "entity_id": "T293",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 67,
              "end_idx": 69,
              "entity_en": "continued"
            },
            {
              "entity_id": "T294",
              "entity": "静脉泵注",
              "entity_type": "Method",
              "start_idx": 69,
              "end_idx": 73,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T295",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 73,
              "end_idx": 76,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T296",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 81,
              "end_idx": 83,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T297",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 83,
              "end_idx": 85,
              "entity_en": "fluctuation"
            },
            {
              "entity_id": "T298",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 86,
              "end_idx": 89,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T299",
              "entity": "静脉",
              "entity_type": "Method",
              "start_idx": 99,
              "end_idx": 101,
              "entity_en": "vein"
            },
            {
              "entity_id": "T300",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 101,
              "end_idx": 104,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T301",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 111,
              "end_idx": 113,
              "entity_en": "continued"
            },
            {
              "entity_id": "T302",
              "entity": "静脉泵注",
              "entity_type": "Method",
              "start_idx": 113,
              "end_idx": 117,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T303",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 117,
              "end_idx": 120,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T304",
              "entity": "应激性高血糖",
              "entity_type": "Disease",
              "start_idx": 121,
              "end_idx": 127,
              "entity_en": "Stress-induced hyperglycemia"
            },
            {
              "entity_id": "T305",
              "entity": "应激性",
              "entity_type": "Class",
              "start_idx": 121,
              "end_idx": 124,
              "entity_en": "Stress"
            },
            {
              "entity_id": "T306",
              "entity": "单次或间断",
              "entity_type": "Frequency",
              "start_idx": 133,
              "end_idx": 138,
              "entity_en": "Single or intermittent"
            },
            {
              "entity_id": "T307",
              "entity": "静脉推注",
              "entity_type": "Method",
              "start_idx": 138,
              "end_idx": 142,
              "entity_en": "IV push"
            },
            {
              "entity_id": "T308",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 142,
              "end_idx": 145,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T309",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 147,
              "end_idx": 149,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T310",
              "entity": "仍高",
              "entity_type": "Test_Value",
              "start_idx": 149,
              "end_idx": 151,
              "entity_en": "Still high"
            },
            {
              "entity_id": "T311",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 154,
              "end_idx": 156,
              "entity_en": "continued"
            },
            {
              "entity_id": "T312",
              "entity": "泵注",
              "entity_type": "Method",
              "start_idx": 156,
              "end_idx": 158,
              "entity_en": "Pump"
            },
            {
              "entity_id": "T313",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 163,
              "end_idx": 168,
              "entity_en": "Short-acting insulin"
            },
            {
              "entity_id": "T314",
              "entity": "生理盐水",
              "entity_type": "Drug",
              "start_idx": 170,
              "end_idx": 174,
              "entity_en": "Normal saline"
            },
            {
              "entity_id": "T315",
              "entity": "浓度1U/ml",
              "entity_type": "Amount",
              "start_idx": 175,
              "end_idx": 182,
              "entity_en": "Concentration 1U/ml"
            },
            {
              "entity_id": "T316",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 190,
              "end_idx": 192,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T317",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 197,
              "end_idx": 200,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T318",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 215,
              "end_idx": 218,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T319",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 229,
              "end_idx": 231,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T320",
              "entity": "升降",
              "entity_type": "Test_Value",
              "start_idx": 231,
              "end_idx": 233,
              "entity_en": "Lift"
            },
            {
              "entity_id": "T321",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 252,
              "end_idx": 255,
              "entity_en": "Hypoglycemia"
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R86",
              "head_entity_id": "T290",
              "tail_entity_id": "T291"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R87",
              "head_entity_id": "T292",
              "tail_entity_id": "T291"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R88",
              "head_entity_id": "T293",
              "tail_entity_id": "T295"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R89",
              "head_entity_id": "T294",
              "tail_entity_id": "T295"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R90",
              "head_entity_id": "T296",
              "tail_entity_id": "T298"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R91",
              "head_entity_id": "T300",
              "tail_entity_id": "T298"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R92",
              "head_entity_id": "T303",
              "tail_entity_id": "T298"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R93",
              "head_entity_id": "T299",
              "tail_entity_id": "T300"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R94",
              "head_entity_id": "T301",
              "tail_entity_id": "T303"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R95",
              "head_entity_id": "T302",
              "tail_entity_id": "T303"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R96",
              "head_entity_id": "T305",
              "tail_entity_id": "T304"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R97",
              "head_entity_id": "T308",
              "tail_entity_id": "T304"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R98",
              "head_entity_id": "T309",
              "tail_entity_id": "T304"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R99",
              "head_entity_id": "T306",
              "tail_entity_id": "T308"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R100",
              "head_entity_id": "T307",
              "tail_entity_id": "T308"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R101",
              "head_entity_id": "T311",
              "tail_entity_id": "T308"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R102",
              "head_entity_id": "T312",
              "tail_entity_id": "T308"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R103",
              "head_entity_id": "T315",
              "tail_entity_id": "T313"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R104",
              "head_entity_id": "T315",
              "tail_entity_id": "T314"
            }
          ],
          "sentence_en": "3. Start insulin treatment when blood sugar is >180mg/dl (10.0mmol/L). Intravenous insulin takes effect quickly and is convenient for titration. It is suitable for intravenous administration during surgery and in the ICU after surgery. Continuous intravenous insulin infusion helps reduce blood sugar fluctuations. Continuous intravenous insulin infusion is the first choice for diabetic patients and patients who have used intravenous insulin before surgery. Patients with stress hyperglycemia can choose a single or intermittent intravenous push of insulin. If the blood sugar is still high, continuous pumping is given. Short-acting insulin is usually added to normal saline with a concentration of 1U/ml and pumped. The amount of insulin is determined by referring to the patient's blood sugar level, preoperative insulin dosage, surgical stimulation and other factors. Close monitoring is performed, and the pump speed is adjusted appropriately according to the rise and fall of blood sugar. Pay attention to individualized medication to avoid hypoglycemia."
        },
        {
          "sentence_id": "1",
          "sentence": "胰岛素皮下注射适合病情稳定的非重症患者，常用于术前术后过渡；注意避免短时问内反复给药造成降糖药效叠加。",
          "start_idx": 256,
          "end_idx": 307,
          "entities": [
            {
              "entity_id": "T322",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 3,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T323",
              "entity": "皮下注射",
              "entity_type": "Method",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Subcutaneous injection"
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R105",
              "head_entity_id": "T323",
              "tail_entity_id": "T322"
            }
          ],
          "sentence_en": "Subcutaneous injection of insulin is suitable for non-critical patients with stable conditions and is often used for transition before and after surgery. Care should be taken to avoid repeated administration within a short period of time to prevent the duplication of hypoglycemic drug effects."
        }
      ],
      "paragraph_en": "3. Start insulin therapy when blood sugar is >180mg/dl (10.0mmol/L). Intravenous insulin takes effect quickly and is convenient for titration. It is suitable for intravenous administration during surgery and in the ICU after surgery. Continuous intravenous insulin infusion is beneficial for reducing blood sugar fluctuations. Continuous intravenous insulin infusion is the first choice for diabetic patients and patients who have used intravenous insulin before surgery. Patients with stress hyperglycemia can choose a single or intermittent intravenous push of insulin. If the blood sugar is still high, continuous pumping is given. Short-acting insulin is usually added to normal saline with a concentration of 1U/ml and pumped. The amount of insulin is determined by referring to the patient's blood sugar level, preoperative insulin dosage, surgical stimulation and other factors. Close monitoring is performed, and the pump speed is appropriately adjusted according to the rise and fall of blood sugar. Pay attention to individualized administration to avoid hypoglycemia. Subcutaneous insulin injection is suitable for non-critical patients with stable conditions and is often used for transition before and after surgery; be careful to avoid repeated administration within a short period of time to cause the hypoglycemic effect to overlap."
    },
    {
      "paragraph_id": "31",
      "paragraph": "4.严重高血糖可能造成渗透性利尿，引起高渗性脱水和低钾血症，应注意维持水电解质平衡。术中由于多数患者血糖水平增高，一般输注无糖液体。术后和过长时间的手术当中，为了减少酮体合成和酸中毒风险，在血糖<250mg/dl(13.9mmol/L)的前提下，静脉泵注胰岛素的同时可泵注加入中和比例胰岛素的含糖液体，根据测得的血糖水平调节泵速。胰岛素+糖双泵同时输注有利于减少血糖波动，但可能促使钾向细胞内转移，进一步加重低钾血症。因此，持续静脉泵注胰岛素时应注意监测血钾，可预防性补钾。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4.严重高血糖可能造成渗透性利尿，引起高渗性脱水和低钾血症，应注意维持水电解质平衡。术中由于多数患者血糖水平增高，一般输注无糖液体。术后和过长时间的手术当中，为了减少酮体合成和酸中毒风险，在血糖<250mg/dl(13.9mmol/L)的前提下，静脉泵注胰岛素的同时可泵注加入中和比例胰岛素的含糖液体，根据测得的血糖水平调节泵速。胰岛素+糖双泵同时输注有利于减少血糖波动，但可能促使钾向细胞内转移，进一步加重低钾血症。因此，持续静脉泵注胰岛素时应注意监测血钾，可预防性补钾。",
          "start_idx": 0,
          "end_idx": 237,
          "entities": [
            {
              "entity_id": "T324",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 2,
              "end_idx": 4,
              "entity_en": "serious"
            },
            {
              "entity_id": "T325",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 7,
              "entity_en": "High blood sugar"
            },
            {
              "entity_id": "T326",
              "entity": "渗透性利尿",
              "entity_type": "Symptom",
              "start_idx": 11,
              "end_idx": 16,
              "entity_en": "Osmotic diuresis"
            },
            {
              "entity_id": "T327",
              "entity": "高渗性脱水",
              "entity_type": "Disease",
              "start_idx": 19,
              "end_idx": 24,
              "entity_en": "Hypertonic dehydration"
            },
            {
              "entity_id": "T328",
              "entity": "高渗性",
              "entity_type": "Class",
              "start_idx": 19,
              "end_idx": 22,
              "entity_en": "Hypertonicity"
            },
            {
              "entity_id": "T329",
              "entity": "低钾血症",
              "entity_type": "Disease",
              "start_idx": 25,
              "end_idx": 29,
              "entity_en": "Hypokalemia"
            },
            {
              "entity_id": "T330",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 50,
              "end_idx": 52,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T331",
              "entity": "增高",
              "entity_type": "Test_Value",
              "start_idx": 54,
              "end_idx": 56,
              "entity_en": "Increase"
            },
            {
              "entity_id": "T332",
              "entity": "输注",
              "entity_type": "Method",
              "start_idx": 59,
              "end_idx": 61,
              "entity_en": "Infusion"
            },
            {
              "entity_id": "T333",
              "entity": "酮体合成",
              "entity_type": "ADE",
              "start_idx": 83,
              "end_idx": 87,
              "entity_en": "Ketone body synthesis"
            },
            {
              "entity_id": "T334",
              "entity": "酸中毒",
              "entity_type": "ADE",
              "start_idx": 88,
              "end_idx": 91,
              "entity_en": "Acidosis"
            },
            {
              "entity_id": "T335",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 95,
              "end_idx": 97,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T336",
              "entity": "<250mg/dl(13.9mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 97,
              "end_idx": 118,
              "entity_en": "<250 mg/dL (13.9 mmol/L)"
            },
            {
              "entity_id": "T337",
              "entity": "静脉泵注",
              "entity_type": "Method",
              "start_idx": 123,
              "end_idx": 127,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T338",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 127,
              "end_idx": 130,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T339",
              "entity": "泵注",
              "entity_type": "Method",
              "start_idx": 134,
              "end_idx": 136,
              "entity_en": "Pump"
            },
            {
              "entity_id": "T340",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 142,
              "end_idx": 145,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T341",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 156,
              "end_idx": 158,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T342",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 165,
              "end_idx": 168,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T343",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 181,
              "end_idx": 183,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T344",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 183,
              "end_idx": 185,
              "entity_en": "fluctuation"
            },
            {
              "entity_id": "T345",
              "entity": "钾向细胞内转移",
              "entity_type": "Pathogenesis",
              "start_idx": 191,
              "end_idx": 198,
              "entity_en": "Potassium moves into cells"
            },
            {
              "entity_id": "T346",
              "entity": "加重",
              "entity_type": "Level",
              "start_idx": 202,
              "end_idx": 204,
              "entity_en": "Aggravation"
            },
            {
              "entity_id": "T347",
              "entity": "低钾血症",
              "entity_type": "Disease",
              "start_idx": 204,
              "end_idx": 208,
              "entity_en": "Hypokalemia"
            },
            {
              "entity_id": "T348",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 212,
              "end_idx": 214,
              "entity_en": "continued"
            },
            {
              "entity_id": "T349",
              "entity": "静脉泵注",
              "entity_type": "Method",
              "start_idx": 214,
              "end_idx": 218,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T350",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 218,
              "end_idx": 221,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T351",
              "entity": "血钾",
              "entity_type": "Test_items",
              "start_idx": 227,
              "end_idx": 229,
              "entity_en": "Serum potassium"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R106",
              "head_entity_id": "T326",
              "tail_entity_id": "T325"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R107",
              "head_entity_id": "T328",
              "tail_entity_id": "T327"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R108",
              "head_entity_id": "T337",
              "tail_entity_id": "T338"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R109",
              "head_entity_id": "T339",
              "tail_entity_id": "T340"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R110",
              "head_entity_id": "T343",
              "tail_entity_id": "T347"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R111",
              "head_entity_id": "T345",
              "tail_entity_id": "T347"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R112",
              "head_entity_id": "T348",
              "tail_entity_id": "T350"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R113",
              "head_entity_id": "T349",
              "tail_entity_id": "T350"
            }
          ],
          "sentence_en": "4. Severe hyperglycemia may cause osmotic diuresis, hyperosmotic dehydration and hypokalemia, and attention should be paid to maintaining water and electrolyte balance. During surgery, since most patients have increased blood sugar levels, sugar-free fluids are generally infused. After surgery and during prolonged surgery, in order to reduce the risk of ketone body synthesis and acidosis, under the premise that blood sugar is <250mg/dl (13.9mmol/L), while intravenously pumping insulin, a sugar-containing liquid with a neutralizing ratio of insulin can be pumped, and the pump speed can be adjusted according to the measured blood sugar level. Simultaneous infusion of insulin + sugar pumps is beneficial to reduce blood sugar fluctuations, but it may promote the transfer of potassium into cells, further aggravating hypokalemia. Therefore, during continuous intravenous infusion of insulin, attention should be paid to monitoring blood potassium, and potassium supplementation can be preventively performed."
        }
      ],
      "paragraph_en": "4. Severe hyperglycemia may cause osmotic diuresis, hyperosmotic dehydration and hypokalemia, and attention should be paid to maintaining water and electrolyte balance. During surgery, since most patients have increased blood sugar levels, sugar-free fluids are generally infused. After surgery and during prolonged surgery, in order to reduce the risk of ketone body synthesis and acidosis, under the premise that blood sugar is <250mg/dl (13.9mmol/L), while intravenous insulin is infused, sugar-containing fluids with neutralizing insulin can be pumped, and the pump speed can be adjusted according to the measured blood sugar level. Simultaneous infusion of insulin + sugar pumps is beneficial to reduce blood sugar fluctuations, but it may promote the transfer of potassium into cells, further aggravating hypokalemia. Therefore, during continuous intravenous infusion of insulin, attention should be paid to monitoring blood potassium, and potassium supplementation can be preventively performed."
    },
    {
      "paragraph_id": "32",
      "paragraph": "低血糖",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "低血糖",
          "start_idx": 0,
          "end_idx": 3,
          "entities": [
            {
              "entity_id": "T352",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 3,
              "entity_en": "Hypoglycemia"
            }
          ],
          "relations": [],
          "sentence_en": "Hypoglycemia"
        }
      ],
      "paragraph_en": "Hypoglycemia"
    },
    {
      "paragraph_id": "33",
      "paragraph": "1.低血糖的危害超过高血糖。血糖≤50mg/dl(2.8mmol/L)时出现认知功能障碍，长时间≤40mg/dl(2.2mmol/L)的严重低血糖可造成脑死亡。发生一次低血糖围术期死亡率即可增加。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.低血糖的危害超过高血糖。",
          "start_idx": 0,
          "end_idx": 14,
          "entities": [
            {
              "entity_id": "T353",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 5,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T354",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 13,
              "entity_en": "High blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "1. The harm of hypoglycemia exceeds that of hyperglycemia."
        },
        {
          "sentence_id": "1",
          "sentence": "血糖≤50mg/dl(2.8mmol/L)时出现认知功能障碍，长时间≤40mg/dl(2.2mmol/L)的严重低血糖可造成脑死亡。",
          "start_idx": 14,
          "end_idx": 80,
          "entities": [
            {
              "entity_id": "T355",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T356",
              "entity": "≤50mg/dl(2.8mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 2,
              "end_idx": 21,
              "entity_en": "≤50 mg/dL (2.8 mmol/L)"
            },
            {
              "entity_id": "T357",
              "entity": "≤40mg/dl(2.2mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 34,
              "end_idx": 53,
              "entity_en": "≤40 mg/dL (2.2 mmol/L)"
            },
            {
              "entity_id": "T358",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 54,
              "end_idx": 56,
              "entity_en": "serious"
            },
            {
              "entity_id": "T359",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 56,
              "end_idx": 59,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T361",
              "entity": "认知功能障碍",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 30,
              "entity_en": "Cognitive dysfunction"
            },
            {
              "entity_id": "T362",
              "entity": "脑死亡",
              "entity_type": "Disease",
              "start_idx": 62,
              "end_idx": 65,
              "entity_en": "Brain Death"
            },
            {
              "entity_id": "T363",
              "entity": "脑",
              "entity_type": "Anatomy",
              "start_idx": 62,
              "end_idx": 63,
              "entity_en": "brain"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R114",
              "head_entity_id": "T355",
              "tail_entity_id": "T361"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R115",
              "head_entity_id": "T363",
              "tail_entity_id": "T362"
            }
          ],
          "sentence_en": "Cognitive dysfunction occurs when blood sugar is ≤50mg/dl (2.8mmol/L), and severe hypoglycemia of ≤40mg/dl (2.2mmol/L) for a long time can cause brain death."
        },
        {
          "sentence_id": "2",
          "sentence": "发生一次低血糖围术期死亡率即可增加。",
          "start_idx": 80,
          "end_idx": 98,
          "entities": [
            {
              "entity_id": "T360",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 7,
              "entity_en": "Hypoglycemia"
            }
          ],
          "relations": [],
          "sentence_en": "A single episode of hypoglycemia can increase perioperative mortality."
        }
      ],
      "paragraph_en": "1. Hypoglycemia is more harmful than hyperglycemia. Cognitive dysfunction occurs when blood sugar is ≤50mg/dl (2.8mmol/L), and severe hypoglycemia of ≤40mg/dl (2.2mmol/L) for a long time can cause brain death. The perioperative mortality rate increases after a single episode of hypoglycemia."
    },
    {
      "paragraph_id": "34",
      "paragraph": "2.低血糖重在预防和及时发现。衰弱、严重感染、肝肾功能不全的患者低血糖风险增加。长期未得到有效控制的糖尿病患者可能在正常的血糖水平即发生低血糖反应。脑损伤患者难以耐受100mg/dl(5.6mmol/L)以下的血糖水平。需要警惕的是，全麻镇静患者的低血糖症状可能被掩盖，不易及时发现。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.低血糖重在预防和及时发现。",
          "start_idx": 0,
          "end_idx": 15,
          "entities": [
            {
              "entity_id": "T364",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 5,
              "entity_en": "Hypoglycemia"
            }
          ],
          "relations": [],
          "sentence_en": "2. The key to hypoglycemia is prevention and timely detection."
        },
        {
          "sentence_id": "1",
          "sentence": "衰弱、严重感染、肝肾功能不全的患者低血糖风险增加。长期未得到有效控制的糖尿病患者可能在正常的血糖水平即发生低血糖反应。脑损伤患者难以耐受100mg/dl(5.6mmol/L)以下的血糖水平。",
          "start_idx": 15,
          "end_idx": 110,
          "entities": [
            {
              "entity_id": "T366",
              "entity": "100mg/dl(5.6mmol/L)以下",
              "entity_type": "Test_Value",
              "start_idx": 68,
              "end_idx": 89,
              "entity_en": "Less than 100 mg/dl (5.6 mmol/L)"
            },
            {
              "entity_id": "T367",
              "entity": "衰弱",
              "entity_type": "Reason",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "weak"
            },
            {
              "entity_id": "T368",
              "entity": "严重感染",
              "entity_type": "Reason",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Severe infection"
            },
            {
              "entity_id": "T369",
              "entity": "肝肾功能不全",
              "entity_type": "Reason",
              "start_idx": 8,
              "end_idx": 14,
              "entity_en": "Liver and kidney dysfunction"
            },
            {
              "entity_id": "T370",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 20,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T371",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 35,
              "end_idx": 38,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T372",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 46,
              "end_idx": 48,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T373",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 53,
              "end_idx": 56,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T374",
              "entity": "脑损伤",
              "entity_type": "Disease",
              "start_idx": 59,
              "end_idx": 62,
              "entity_en": "Brain damage"
            },
            {
              "entity_id": "T375",
              "entity": "脑",
              "entity_type": "Anatomy",
              "start_idx": 59,
              "end_idx": 60,
              "entity_en": "brain"
            },
            {
              "entity_id": "T376",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 90,
              "end_idx": 92,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R116",
              "head_entity_id": "T367",
              "tail_entity_id": "T370"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R117",
              "head_entity_id": "T368",
              "tail_entity_id": "T370"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R118",
              "head_entity_id": "T369",
              "tail_entity_id": "T370"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R119",
              "head_entity_id": "T372",
              "tail_entity_id": "T371"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R120",
              "head_entity_id": "T372",
              "tail_entity_id": "T373"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R121",
              "head_entity_id": "T376",
              "tail_entity_id": "T374"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R122",
              "head_entity_id": "T375",
              "tail_entity_id": "T374"
            }
          ],
          "sentence_en": "Patients with debilitation, severe infection, or impaired liver and kidney function have an increased risk of hypoglycemia. Patients with diabetes who have not been effectively controlled for a long time may experience hypoglycemia at normal blood sugar levels. Patients with brain damage have difficulty tolerating blood sugar levels below 100 mg/dl (5.6 mmol/L)."
        },
        {
          "sentence_id": "2",
          "sentence": "需要警惕的是，全麻镇静患者的低血糖症状可能被掩盖，不易及时发现。",
          "start_idx": 110,
          "end_idx": 142,
          "entities": [
            {
              "entity_id": "T365",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 14,
              "end_idx": 17,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T377",
              "entity": "全麻",
              "entity_type": "Operation",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "General anesthesia"
            }
          ],
          "relations": [],
          "sentence_en": "It is important to be aware that the symptoms of hypoglycemia in patients under general anesthesia and sedation may be masked and difficult to detect in time."
        }
      ],
      "paragraph_en": "2. Hypoglycemia is important to prevent and detect in time. Patients with weakness, severe infection, or liver and kidney dysfunction have an increased risk of hypoglycemia. Long-term uncontrolled diabetes patients may experience hypoglycemia at normal blood sugar levels. Patients with brain damage have difficulty tolerating blood sugar levels below 100 mg/dl (5.6 mmol/L). It is important to be aware that the symptoms of hypoglycemia in patients under general anesthesia and sedation may be masked and difficult to detect in time."
    },
    {
      "paragraph_id": "35",
      "paragraph": "3.静脉输注胰岛素的患者血糖≤100mg/dl(5.6mmol/L)应重新评估，调整泵速。血糖≤70mg/dl(3.9mmol/L)立即停用胰岛素，开始升血糖处理。可进食的清醒患者立即口服10~25g快速吸收的碳水化合物(如含糖饮料)，不能口服的静脉推注50%葡萄糖20~50rnl，之后持续静脉点滴5%或10%葡萄糖维持血糖，每5~15分钟监测一次直至血糖≥100mg/dl(5.6mmol/L)。仔细筛查引起低血糖的可能原因。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.静脉输注胰岛素的患者血糖≤100mg/dl(5.6mmol/L)应重新评估，调整泵速。血糖≤70mg/dl(3.9mmol/L)立即停用胰岛素，开始升血糖处理。可进食的清醒患者立即口服10~25g快速吸收的碳水化合物(如含糖饮料)，不能口服的静脉推注50%葡萄糖20~50rnl，之后持续静脉点滴5%或10%葡萄糖维持血糖，每5~15分钟监测一次直至血糖≥100mg/dl(5.6mmol/L)。",
          "start_idx": 0,
          "end_idx": 200,
          "entities": [
            {
              "entity_id": "T378",
              "entity": "静脉输注",
              "entity_type": "Method",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T379",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 9,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T380",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 12,
              "end_idx": 14,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T381",
              "entity": "≤100mg/dl(5.6mmol/L",
              "entity_type": "Test_Value",
              "start_idx": 14,
              "end_idx": 33,
              "entity_en": "≤100 mg/dl (5.6 mmol/L"
            },
            {
              "entity_id": "T382",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 45,
              "end_idx": 47,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T383",
              "entity": "≤70mg/dl(3.9mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 47,
              "end_idx": 66,
              "entity_en": "≤70 mg/dL (3.9 mmol/L)"
            },
            {
              "entity_id": "T384",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 70,
              "end_idx": 73,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T385",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 77,
              "end_idx": 79,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T386",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 92,
              "end_idx": 94,
              "entity_en": "oral"
            },
            {
              "entity_id": "T387",
              "entity": "10~25g",
              "entity_type": "Amount",
              "start_idx": 94,
              "end_idx": 100,
              "entity_en": "10~25g"
            },
            {
              "entity_id": "T388",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 120,
              "end_idx": 122,
              "entity_en": "oral"
            },
            {
              "entity_id": "T389",
              "entity": "静脉推注",
              "entity_type": "Method",
              "start_idx": 123,
              "end_idx": 127,
              "entity_en": "IV push"
            },
            {
              "entity_id": "T390",
              "entity": "50%葡萄糖",
              "entity_type": "Drug",
              "start_idx": 127,
              "end_idx": 133,
              "entity_en": "50% Glucose"
            },
            {
              "entity_id": "T391",
              "entity": "20~50rnl",
              "entity_type": "Amount",
              "start_idx": 133,
              "end_idx": 141,
              "entity_en": "20~50rnl"
            },
            {
              "entity_id": "T392",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 144,
              "end_idx": 146,
              "entity_en": "continued"
            },
            {
              "entity_id": "T393",
              "entity": "静脉点滴",
              "entity_type": "Method",
              "start_idx": 146,
              "end_idx": 150,
              "entity_en": "Intravenous drip"
            },
            {
              "entity_id": "T394",
              "entity": "5%或10%葡萄糖",
              "entity_type": "Drug",
              "start_idx": 150,
              "end_idx": 159,
              "entity_en": "5% or 10% glucose"
            },
            {
              "entity_id": "T395",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 161,
              "end_idx": 163,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T396",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 177,
              "end_idx": 179,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T397",
              "entity": "≥100mg/dl(5.6mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 179,
              "end_idx": 199,
              "entity_en": "≥100 mg/dL (5.6 mmol/L)"
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R123",
              "head_entity_id": "T378",
              "tail_entity_id": "T379"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R124",
              "head_entity_id": "T391",
              "tail_entity_id": "T390"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R125",
              "head_entity_id": "T392",
              "tail_entity_id": "T394"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R126",
              "head_entity_id": "T393",
              "tail_entity_id": "T394"
            }
          ],
          "sentence_en": "3. Patients receiving intravenous insulin infusion whose blood glucose is ≤100mg/dl (5.6mmol/L) should be re-evaluated and the pump speed should be adjusted. If blood glucose is ≤70mg/dl (3.9mmol/L), insulin should be discontinued immediately and blood glucose treatment should be started. Conscious patients who can eat should immediately take 10-25g of rapidly absorbed carbohydrates (such as sugary drinks) orally. Those who cannot take it orally should receive an intravenous push of 50% glucose 20-50rnl, followed by continuous intravenous drip of 5% or 10% glucose to maintain blood glucose, and monitor every 5-15 minutes until blood glucose is ≥100mg/dl (5.6mmol/L)."
        },
        {
          "sentence_id": "1",
          "sentence": "仔细筛查引起低血糖的可能原因。",
          "start_idx": 200,
          "end_idx": 215,
          "entities": [
            {
              "entity_id": "T398",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 6,
              "end_idx": 9,
              "entity_en": "Hypoglycemia"
            }
          ],
          "relations": [],
          "sentence_en": "Carefully screen for possible causes of hypoglycemia."
        }
      ],
      "paragraph_en": "3. Patients receiving intravenous insulin infusion whose blood glucose is ≤100mg/dl (5.6mmol/L) should be re-evaluated and the pump speed should be adjusted. If blood glucose is ≤70mg/dl (3.9mmol/L), insulin should be discontinued immediately and blood glucose-raising treatment should be started. Conscious patients who can eat should immediately take 10-25g of rapidly absorbed carbohydrates (such as sugary drinks) orally. Those who cannot take it orally should receive an intravenous push of 50% glucose at 20-50rnl, followed by continuous intravenous drip of 5% or 10% glucose to maintain blood glucose, and monitor every 5-15 minutes until blood glucose is ≥100mg/dl (5.6mmol/L). Carefully screen for possible causes of hypoglycemia."
    },
    {
      "paragraph_id": "36",
      "paragraph": "血糖术后管理",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "血糖术后管理",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [
            {
              "entity_id": "T399",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Postoperative blood sugar management"
        }
      ],
      "paragraph_en": "Postoperative blood sugar management"
    },
    {
      "paragraph_id": "37",
      "paragraph": "术后早期管理",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "术后早期管理",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": [],
          "sentence_en": "Early postoperative management"
        }
      ],
      "paragraph_en": "Early postoperative management"
    },
    {
      "paragraph_id": "38",
      "paragraph": "1.术后因疼痛应激、感染、肠内外营养液输注，是血糖波动的高危时期，也是血糖管理的重要时期。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.术后因疼痛应激、感染、肠内外营养液输注，是血糖波动的高危时期，也是血糖管理的重要时期。",
          "start_idx": 0,
          "end_idx": 45,
          "entities": [
            {
              "entity_id": "T400",
              "entity": "疼痛应激",
              "entity_type": "Symptom",
              "start_idx": 5,
              "end_idx": 9,
              "entity_en": "Pain stress"
            },
            {
              "entity_id": "T401",
              "entity": "感染",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 12,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T402",
              "entity": "肠内外营养液",
              "entity_type": "Drug",
              "start_idx": 13,
              "end_idx": 19,
              "entity_en": "Enteral nutrition solution"
            },
            {
              "entity_id": "T403",
              "entity": "输注",
              "entity_type": "Method",
              "start_idx": 19,
              "end_idx": 21,
              "entity_en": "Infusion"
            },
            {
              "entity_id": "T404",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 23,
              "end_idx": 25,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T405",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 25,
              "end_idx": 27,
              "entity_en": "fluctuation"
            },
            {
              "entity_id": "T406",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 35,
              "end_idx": 37,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R127",
              "head_entity_id": "T403",
              "tail_entity_id": "T402"
            }
          ],
          "sentence_en": "1. Postoperatively, due to pain stress, infection, and enteral and parenteral nutrition infusion, it is a high-risk period for blood sugar fluctuations and an important period for blood sugar management."
        }
      ],
      "paragraph_en": "1. Postoperatively, due to pain stress, infection, and enteral and parenteral nutrition infusion, it is a high-risk period for blood sugar fluctuations and an important period for blood sugar management."
    },
    {
      "paragraph_id": "39",
      "paragraph": "2.术中持续静脉泵注胰岛素者，建议术后继续泵注24小时以上。机械通气和应用血管活性药物的ICU患者容易出现血糖波动，胰岛素应静脉泵注。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.术中持续静脉泵注胰岛素者，建议术后继续泵注24小时以上。机械通气和应用血管活性药物的ICU患者容易出现血糖波动，胰岛素应静脉泵注。",
          "start_idx": 0,
          "end_idx": 67,
          "entities": [
            {
              "entity_id": "T407",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 4,
              "end_idx": 6,
              "entity_en": "continued"
            },
            {
              "entity_id": "T408",
              "entity": "静脉泵注",
              "entity_type": "Method",
              "start_idx": 6,
              "end_idx": 10,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T409",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 13,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T410",
              "entity": "泵注",
              "entity_type": "Method",
              "start_idx": 21,
              "end_idx": 23,
              "entity_en": "Pump"
            },
            {
              "entity_id": "T411",
              "entity": "24小时以上",
              "entity_type": "Duration",
              "start_idx": 23,
              "end_idx": 29,
              "entity_en": "More than 24 hours"
            },
            {
              "entity_id": "T412",
              "entity": "机械通气",
              "entity_type": "Treatment",
              "start_idx": 30,
              "end_idx": 34,
              "entity_en": "Mechanical ventilation"
            },
            {
              "entity_id": "T413",
              "entity": "血管活性药物",
              "entity_type": "Drug",
              "start_idx": 37,
              "end_idx": 43,
              "entity_en": "Vasoactive drugs"
            },
            {
              "entity_id": "T414",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 53,
              "end_idx": 55,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T415",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 55,
              "end_idx": 57,
              "entity_en": "fluctuation"
            },
            {
              "entity_id": "T416",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 58,
              "end_idx": 61,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T417",
              "entity": "静脉泵注",
              "entity_type": "Method",
              "start_idx": 62,
              "end_idx": 66,
              "entity_en": "Intravenous infusion"
            }
          ],
          "relations": [
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R128",
              "head_entity_id": "T407",
              "tail_entity_id": "T409"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R129",
              "head_entity_id": "T408",
              "tail_entity_id": "T409"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R130",
              "head_entity_id": "T411",
              "tail_entity_id": "T409"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R131",
              "head_entity_id": "T410",
              "tail_entity_id": "T409"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R132",
              "head_entity_id": "T417",
              "tail_entity_id": "T416"
            }
          ],
          "sentence_en": "2. For patients who receive continuous intravenous insulin pumping during surgery, it is recommended to continue the pumping for more than 24 hours after surgery. ICU patients who are mechanically ventilated and use vasoactive drugs are prone to blood sugar fluctuations, and insulin should be injected intravenously."
        }
      ],
      "paragraph_en": "2. For patients who receive continuous intravenous insulin pumping during surgery, it is recommended to continue the pumping for more than 24 hours after surgery. ICU patients who are mechanically ventilated and use vasoactive drugs are prone to blood sugar fluctuations, and insulin should be injected intravenously."
    },
    {
      "paragraph_id": "40",
      "paragraph": "3.病情稳定后过渡到皮下注射胰岛素。根据过渡前静脉泵速推算皮下胰岛素剂量。皮下注射和静脉泵注应有2小时左右的重叠，便于平稳过渡。积极预防术后恶心呕吐，尽早恢复正常饮食，根据进食情况逐步增加餐前短效胰岛素剂量。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.病情稳定后过渡到皮下注射胰岛素。根据过渡前静脉泵速推算皮下胰岛素剂量。皮下注射和静脉泵注应有2小时左右的重叠，便于平稳过渡。",
          "start_idx": 0,
          "end_idx": 64,
          "entities": [
            {
              "entity_id": "T418",
              "entity": "皮下注射",
              "entity_type": "Method",
              "start_idx": 10,
              "end_idx": 14,
              "entity_en": "Subcutaneous injection"
            },
            {
              "entity_id": "T419",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 17,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T420",
              "entity": "静脉泵",
              "entity_type": "Method",
              "start_idx": 23,
              "end_idx": 26,
              "entity_en": "Intravenous pump"
            },
            {
              "entity_id": "T421",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 31,
              "end_idx": 34,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T422",
              "entity": "皮下注射",
              "entity_type": "Method",
              "start_idx": 37,
              "end_idx": 41,
              "entity_en": "Subcutaneous injection"
            },
            {
              "entity_id": "T423",
              "entity": "静脉泵",
              "entity_type": "Method",
              "start_idx": 42,
              "end_idx": 45,
              "entity_en": "Intravenous pump"
            },
            {
              "entity_id": "T424",
              "entity": "2小时",
              "entity_type": "Duration",
              "start_idx": 48,
              "end_idx": 51,
              "entity_en": "2 hours"
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R133",
              "head_entity_id": "T418",
              "tail_entity_id": "T419"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R134",
              "head_entity_id": "T420",
              "tail_entity_id": "T421"
            }
          ],
          "sentence_en": "3. After the condition stabilizes, transition to subcutaneous insulin injection. The subcutaneous insulin dose is calculated based on the intravenous pump speed before the transition. There should be an overlap of about 2 hours between subcutaneous injection and intravenous pumping to facilitate a smooth transition."
        },
        {
          "sentence_id": "1",
          "sentence": "积极预防术后恶心呕吐，尽早恢复正常饮食，根据进食情况逐步增加餐前短效胰岛素剂量。",
          "start_idx": 64,
          "end_idx": 104,
          "entities": [
            {
              "entity_id": "T425",
              "entity": "恶心",
              "entity_type": "ADE",
              "start_idx": 6,
              "end_idx": 8,
              "entity_en": "nausea"
            },
            {
              "entity_id": "T426",
              "entity": "呕吐",
              "entity_type": "ADE",
              "start_idx": 8,
              "end_idx": 10,
              "entity_en": "Vomit"
            },
            {
              "entity_id": "T427",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 32,
              "end_idx": 37,
              "entity_en": "Short-acting insulin"
            }
          ],
          "relations": [],
          "sentence_en": "Actively prevent postoperative nausea and vomiting, resume normal diet as soon as possible, and gradually increase the dose of short-acting insulin before meals according to eating habits."
        }
      ],
      "paragraph_en": "3. After the condition stabilizes, transition to subcutaneous insulin injection. Calculate the subcutaneous insulin dose based on the intravenous pump speed before transition. There should be an overlap of about 2 hours between subcutaneous injection and intravenous pumping to facilitate a smooth transition. Actively prevent postoperative nausea and vomiting, resume normal diet as soon as possible, and gradually increase the dose of short-acting insulin before meals according to eating habits."
    },
    {
      "paragraph_id": "41",
      "paragraph": "出院前准备",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "出院前准备",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": [],
          "sentence_en": "Preparation before discharge"
        }
      ],
      "paragraph_en": "Preparation before discharge"
    },
    {
      "paragraph_id": "42",
      "paragraph": "1.长期胰岛素治疗的患者在出院前1~2天恢复原有方案。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.长期胰岛素治疗的患者在出院前1~2天恢复原有方案。",
          "start_idx": 0,
          "end_idx": 27,
          "entities": [
            {
              "entity_id": "T428",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 7,
              "entity_en": "insulin"
            }
          ],
          "relations": [],
          "sentence_en": "1. Patients receiving long-term insulin therapy should resume their original regimen 1 to 2 days before discharge."
        }
      ],
      "paragraph_en": "1. Patients receiving long-term insulin therapy should resume their original regimen 1 to 2 days before discharge."
    },
    {
      "paragraph_id": "43",
      "paragraph": "2.饮食正常规律、器官功能稳定后，如无禁忌证，可恢复口服降糖药。二甲双胍在肾功能稳定后加用，并且不早于术后48小时。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.饮食正常规律、器官功能稳定后，如无禁忌证，可恢复口服降糖药。",
          "start_idx": 0,
          "end_idx": 32,
          "entities": [
            {
              "entity_id": "T429",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 26,
              "end_idx": 28,
              "entity_en": "oral"
            }
          ],
          "relations": [],
          "sentence_en": "2. After the diet is normal and organ function is stable, oral hypoglycemic drugs can be resumed if there are no contraindications."
        },
        {
          "sentence_id": "1",
          "sentence": "二甲双胍在肾功能稳定后加用，并且不早于术后48小时。",
          "start_idx": 32,
          "end_idx": 58,
          "entities": [
            {
              "entity_id": "T430",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Metformin"
            }
          ],
          "relations": [],
          "sentence_en": "Metformin was added after renal function was stable and no earlier than 48 hours after surgery."
        }
      ],
      "paragraph_en": "2. After the diet is normal and organ function is stable, oral hypoglycemic drugs can be resumed if there are no contraindications. Metformin should be added after renal function is stable, and no earlier than 48 hours after surgery."
    },
    {
      "paragraph_id": "44",
      "paragraph": "3.对于围术期新发现的糖尿病患者以及调整了治疗方案的患者，应进行出院前宣教，安排内分泌科随诊。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.对于围术期新发现的糖尿病患者以及调整了治疗方案的患者，应进行出院前宣教，安排内分泌科随诊。",
          "start_idx": 0,
          "end_idx": 47,
          "entities": [
            {
              "entity_id": "T431",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 14,
              "entity_en": "diabetes"
            }
          ],
          "relations": [],
          "sentence_en": "3. For patients with newly discovered diabetes in the perioperative period and patients whose treatment plans have been adjusted, pre-discharge education should be conducted and follow-up visits with the endocrinology department should be arranged."
        }
      ],
      "paragraph_en": "3. For patients with newly discovered diabetes in the perioperative period and patients whose treatment plans have been adjusted, pre-discharge education should be conducted and follow-up visits with the endocrinology department should be arranged."
    },
    {
      "paragraph_id": "45",
      "paragraph": "4.门诊手术术后监测直至排除低血糖风险后方可离院。皮下注射速效胰岛素1.5小时内、常规胰岛素3~4小时内有发生低血糖的危险。离院途中应随身携带含糖饮料。常规降糖治疗需推迟到恢复正常饮食以后。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4.门诊手术术后监测直至排除低血糖风险后方可离院。皮下注射速效胰岛素1.5小时内、常规胰岛素3~4小时内有发生低血糖的危险。",
          "start_idx": 0,
          "end_idx": 62,
          "entities": [
            {
              "entity_id": "T432",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 14,
              "end_idx": 17,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T433",
              "entity": "皮下注射",
              "entity_type": "Method",
              "start_idx": 25,
              "end_idx": 29,
              "entity_en": "Subcutaneous injection"
            },
            {
              "entity_id": "T434",
              "entity": "速效胰岛素",
              "entity_type": "Drug",
              "start_idx": 29,
              "end_idx": 34,
              "entity_en": "Rapid-acting insulin"
            },
            {
              "entity_id": "T435",
              "entity": "常规胰岛素",
              "entity_type": "Drug",
              "start_idx": 41,
              "end_idx": 46,
              "entity_en": "Regular insulin"
            },
            {
              "entity_id": "T436",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 55,
              "end_idx": 58,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T437",
              "entity": "1.5小时",
              "entity_type": "Duration",
              "start_idx": 34,
              "end_idx": 39,
              "entity_en": "1.5 hours"
            },
            {
              "entity_id": "T438",
              "entity": "3~4小时",
              "entity_type": "Duration",
              "start_idx": 46,
              "end_idx": 51,
              "entity_en": "3~4 hours"
            }
          ],
          "relations": [
            {
              "relation_type": "Method_Drug",
              "relation_id": "R135",
              "head_entity_id": "T433",
              "tail_entity_id": "T434"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R136",
              "head_entity_id": "T433",
              "tail_entity_id": "T435"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R137",
              "head_entity_id": "T436",
              "tail_entity_id": "T434"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R138",
              "head_entity_id": "T437",
              "tail_entity_id": "T434"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R139",
              "head_entity_id": "T436",
              "tail_entity_id": "T435"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R140",
              "head_entity_id": "T438",
              "tail_entity_id": "T435"
            }
          ],
          "sentence_en": "4. Patients undergoing outpatient surgery should be monitored after surgery until the risk of hypoglycemia is ruled out. There is a risk of hypoglycemia within 1.5 hours of subcutaneous injection of rapid-acting insulin and within 3 to 4 hours of regular insulin."
        },
        {
          "sentence_id": "1",
          "sentence": "离院途中应随身携带含糖饮料。",
          "start_idx": 62,
          "end_idx": 76,
          "entities": [],
          "relations": [],
          "sentence_en": "You should carry sugary drinks with you when you leave the hospital."
        },
        {
          "sentence_id": "2",
          "sentence": "常规降糖治疗需推迟到恢复正常饮食以后。",
          "start_idx": 76,
          "end_idx": 95,
          "entities": [],
          "relations": [],
          "sentence_en": "Conventional hypoglycemic treatment should be postponed until a normal diet is resumed."
        }
      ],
      "paragraph_en": "4. Patients undergoing outpatient surgery should be monitored after surgery until the risk of hypoglycemia is ruled out before leaving the hospital. There is a risk of hypoglycemia within 1.5 hours of subcutaneous injection of rapid-acting insulin and within 3 to 4 hours of regular insulin. Sugary drinks should be brought with you when leaving the hospital. Conventional hypoglycemic treatment should be postponed until a normal diet is resumed."
    },
    {
      "paragraph_id": "46",
      "paragraph": "小结",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "小结",
          "start_idx": 0,
          "end_idx": 2,
          "entities": [],
          "relations": [],
          "sentence_en": "summary"
        }
      ],
      "paragraph_en": "summary"
    },
    {
      "paragraph_id": "47",
      "paragraph": "围术期血糖管理对于减少血糖异常相关的并发症、促进患者术后快速康复、改善手术患者预后具有重要意义。术前筛查糖化血红蛋白有助于识别围术期高血糖相关不良事件的高危人群。“合理、有效、安全”是血糖管理的宗旨，围术期血糖目标值定为140mg/dl(7.8mmol/L)~180mg/dl(10.0mmol/L)兼顾了血糖管理的有效性和安全性，较为合理。血糖>180mg/dl(10.0mmol/L)即可启动胰岛素治疗，短效胰岛素持续静脉泵注便于及时调整剂量，减少血糖波动，是高危患者围术期血糖控制的首选方案。严密监测血糖，个体化管理，方可实现围术期平稳过渡。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "围术期血糖管理对于减少血糖异常相关的并发症、促进患者术后快速康复、改善手术患者预后具有重要意义。术前筛查糖化血红蛋白有助于识别围术期高血糖相关不良事件的高危人群。“合理、有效、安全”是血糖管理的宗旨，围术期血糖目标值定为140mg/dl(7.8mmol/L)~180mg/dl(10.0mmol/L)兼顾了血糖管理的有效性和安全性，较为合理。血糖>180mg/dl(10.0mmol/L)即可启动胰岛素治疗，短效胰岛素持续静脉泵注便于及时调整剂量，减少血糖波动，是高危患者围术期血糖控制的首选方案。",
          "start_idx": 0,
          "end_idx": 249,
          "entities": [
            {
              "entity_id": "T439",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T440",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 11,
              "end_idx": 13,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T441",
              "entity": "异常",
              "entity_type": "Test_Value",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "abnormal"
            },
            {
              "entity_id": "T442",
              "entity": "糖化血红蛋白",
              "entity_type": "Test_items",
              "start_idx": 52,
              "end_idx": 58,
              "entity_en": "Glycated hemoglobin"
            },
            {
              "entity_id": "T443",
              "entity": "高血糖",
              "entity_type": "Disease",
              "start_idx": 66,
              "end_idx": 69,
              "entity_en": "High blood sugar"
            },
            {
              "entity_id": "T444",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 92,
              "end_idx": 94,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T445",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 103,
              "end_idx": 105,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T446",
              "entity": "140mg/dl(7.8mmol/L)~180mg/dl(10.0mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 110,
              "end_idx": 150,
              "entity_en": "140mg/dl(7.8mmol/L)~180mg/dl(10.0mmol/L)"
            },
            {
              "entity_id": "T447",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 153,
              "end_idx": 155,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T448",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 171,
              "end_idx": 173,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T449",
              "entity": ">180mg/dl(10.0mmol/L)",
              "entity_type": "Test_Value",
              "start_idx": 173,
              "end_idx": 194,
              "entity_en": ">180 mg/dL (10.0 mmol/L)"
            },
            {
              "entity_id": "T450",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 198,
              "end_idx": 201,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T451",
              "entity": "短效胰岛素",
              "entity_type": "Drug",
              "start_idx": 204,
              "end_idx": 209,
              "entity_en": "Short-acting insulin"
            },
            {
              "entity_id": "T452",
              "entity": "持续",
              "entity_type": "Duration",
              "start_idx": 209,
              "end_idx": 211,
              "entity_en": "continued"
            },
            {
              "entity_id": "T453",
              "entity": "静脉泵注",
              "entity_type": "Method",
              "start_idx": 211,
              "end_idx": 215,
              "entity_en": "Intravenous infusion"
            },
            {
              "entity_id": "T454",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 226,
              "end_idx": 228,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T455",
              "entity": "波动",
              "entity_type": "Test_Value",
              "start_idx": 228,
              "end_idx": 230,
              "entity_en": "fluctuation"
            },
            {
              "entity_id": "T456",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 239,
              "end_idx": 241,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R141",
              "head_entity_id": "T442",
              "tail_entity_id": "T443"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R142",
              "head_entity_id": "T452",
              "tail_entity_id": "T451"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R143",
              "head_entity_id": "T453",
              "tail_entity_id": "T451"
            }
          ],
          "sentence_en": "Perioperative blood glucose management is of great significance for reducing complications related to abnormal blood glucose, promoting rapid postoperative recovery of patients, and improving the prognosis of surgical patients. Preoperative screening of glycosylated hemoglobin helps to identify high-risk groups for perioperative hyperglycemia-related adverse events. \"Reasonable, effective, and safe\" is the purpose of blood glucose management. The perioperative blood glucose target value is set at 140mg/dl (7.8mmol/L)~180mg/dl (10.0mmol/L), which takes into account the effectiveness and safety of blood glucose management and is more reasonable. Insulin treatment can be started when blood glucose is >180mg/dl (10.0mmol/L). Continuous intravenous infusion of short-acting insulin facilitates timely adjustment of the dose and reduces blood glucose fluctuations. It is the preferred option for perioperative blood glucose control in high-risk patients."
        },
        {
          "sentence_id": "1",
          "sentence": "严密监测血糖，个体化管理，方可实现围术期平稳过渡。",
          "start_idx": 249,
          "end_idx": 274,
          "entities": [
            {
              "entity_id": "T457",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 4,
              "end_idx": 6,
              "entity_en": "blood sugar"
            }
          ],
          "relations": [],
          "sentence_en": "Only by closely monitoring blood sugar and individualized management can a smooth transition during the perioperative period be achieved."
        }
      ],
      "paragraph_en": "Perioperative blood glucose management is of great significance for reducing complications related to abnormal blood glucose, promoting rapid postoperative recovery of patients, and improving the prognosis of surgical patients. Preoperative screening of glycosylated hemoglobin helps to identify high-risk groups for perioperative hyperglycemia-related adverse events. \"Reasonable, effective, and safe\" is the purpose of blood glucose management. The perioperative blood glucose target value is set at 140mg/dl (7.8mmol/L)~180mg/dl (10.0mmol/L), which takes into account the effectiveness and safety of blood glucose management and is more reasonable. Insulin treatment can be started when blood glucose is >180mg/dl (10.0mmol/L). Continuous intravenous infusion of short-acting insulin facilitates timely adjustment of the dose and reduces blood glucose fluctuations. It is the preferred option for perioperative blood glucose control in high-risk patients. Close monitoring of blood glucose and individualized management can achieve a smooth transition during the perioperative period."
    }
  ]
}